OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2026-03-31-accounts

!"#$%&"'"()+,-"'.)!"#!"$!#% /01'$&2)+,-"'.%&"'&(!%

!"##!$%&'($&%)*#'!"+&!!

,-'./01234'5606789':4';<2=23788>!

!"+&!##&?'"#%$"!'-@A'B)@-@*)-C'&!-!#D#@!&!

B$"'!(#'E#-"'#@A#A'FG'D-"*('HIHJ

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

/3456457
81#"
"8K8=83.8239290636L7=276M8987265L/K7N8*/01234O67L!=<L788L23929M6L8=L 9:;
!=<L788L?=81/=7 <:<<
)39818398372<967/=?L=81/=7/37N8K6323.625L72780837L <=:<>
*/3L/5692789L72780837/KK6323.6252.76M6768L <?:<@
*/3L/5692789:2523.8LN887 =A:=9
*/01234:2523.8LN887 =;:=<
*/3L/5692789L72780837/K.2LNK5/PL ((
@/78L7/7N8K6323.625L72780837L =B:><

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

!6C6!64/6))+)DEFG4G75!D5GH6)E65DGI7),-)5J6).,/0)12)G57)5!K75667))+)DEHG76!7% !"#$%&'$(')#$'+'+$,-$.)#/&$0102!

!=<L788L E'!6DL('$(#"
/37M""L"2
/3/NL2**O5'"1%+'"'
F'%PJQ-(12
/3!RSQ*"%
E'/7T1*#
/47T01L$(
F'%/R"-%&"'
E'/8Q&&%
E'F7U1*U$VW
F'ESMQ+&V0"'
*/01234=8;6L78=89 !"#!"$!#
,-./01
*N2=674=8;6L78=89,-./01&"'&(!
"8;6L78=89/KK6.8 5'""&QX%JQ%X$V"
E"'-2!Q1(
!$%L"2
E"'-2%0$'"
E6>;<77
*/01234L8.=872=4 !MQ%&QVWY1XXQ$&"(9ZS1+1'2;A;Z[
*N68K8Q8.<76M8
ST$#0&Y1XXQ$&"(Z3V&Q-"';A;B[
)39818398372<967/= KJPJ1VW"'PQ+*#
/01'&"'"(DVVQ+&1&%
9=81'W!QU
4Q&&$*#01,
4N9ZN!
R23S8=L 71&1("'
M'$(L"!Q1(
MQQ&L"
F"'%"2%$("
NG!ADD
&/56.67/=L 6LL$%C"',Q'\4"#+%
;E"]Q%0$'"D]"+"
M""%&Q*
4Q&&$*#01,
4N@9M7

81#")9%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)REPORT INCLUDING STRATEGIC REPORT

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

567%53849774%:;6<%=37%=>4<%?@37A9<34%<B%967%.<CD=EF%B<3%967%D83D<474%<B%A=;G%X'"%"&%&0"$'%1+1L%'"XQ'&%&Q#"&0"'% U$&0%&0"%1+($&"(%VQ%QL$(1&"()^$1V$1L)%&1&","&%)Q^)&0")V01'$&2)1()$&%)%+-%$($1'$"%)^Q')&0")2"1')9)DX'$L);A;B)&Q)<9)F1'V0) ;A;Z_)50")1+1L)'"XQ'&)%"']"%)&0")X+'XQ%"%)Q^)-Q&0%1%53849774H%'"XQ'&%1(%1%E$'"V&Q'%%'"XQ'&)+*("'% VQ,X1*2% L1U_% 567% 53849774% VQ*^$',% &01&% &0"% 1**+1L% '"XQ'&% 1*(% ^$*1*V$1L% %&1&","*&%% VQ,XL2%U$&0%&0"%V+''"*&%%&1&+&Q'2%'"a+$'","*&%O%&0"% '"a+$'","*&%%<B%&0"%V01'$&1-L"%VQ,X1*2%%#Q]"'$#%(QV+,"&%1()&0"% X'Q]$%$Q%% <B% &0"% 7&1&","&% <B% !"VQ,,"("(% 8'1V&$V"% :I,J0G% 1XXL$V1-L"% &Q% V01'$&$"%% X'"X1'$#% &0"$'% 1VVQ+&%% $)1VVQ'(1V"% U$&0% &0"% C$1V$1L% !"XQ'&$#% 7&1(1'(% 1XXL$V1-L"% $% &0"% KL% 1(% !"X+-L$V% <B% G'"L1*(% :-JI"!MG% :7BB7A9@N7%"%O=E8=3F%M!"'%=E?%8D?=97?%3V&Q-"');A9@[_%

!"#$%&'($)+,-+%&'('&'$)!

2>'%/56.68L'239'/:T8.76M8L!

567%<PQ7A9@N74%B%967%A6=3@9F%=37%Aamp#69;amp#57;amp#61;amp#64;amp#69;amp#55;amp#63;amp#37;amp#64;amp#69;amp#37;amp#66;amp#56;%@E%967%/7C3=E?8C%=E?%)39@A74%B%967%A6=3@9FR%%567F%=37%=4<%A>7=3>F% 49=97?%@E%967%S@4@<E2%/@44@874%49=97C7E9%=E?%=37%48CC=3@47?%=4%B<>><;4T%

23435,!

501&)"]"'2Q")L$]$#)U$&0$)&0")VQ,,+$&$"%)U")%"']")01%)1VV"%%)&Q)"*()Q^)L$^")V1'")Q^)&0")0$#0"%&)a+1L$&2_%

D6LL6/3!

5<%C=U7%7N73F%?=F%A<8E9%9638V6%V@N@EV%967%6@V6749%W8=@9F%48DD<39%B<3%D=9@7E94%=E?%B=C@>@74%>@N@EV%;@96%>@B7%>@C@9@EV%@>>E744 <3%=BB7A97?%PF%?7=96%=E?%?F@EVR%

U25<8L!

!"#$"%&'()&+",('-,"./0&+/1"2"03$"0#/(!

We believe that every person is different but equal, and that everyone’s unique needs and contribu"ons should be recognised and supported with kindness

#Q8=.6L63;'=8L1/3L6:58'L78P2=9LN61!

The commitment of our staff and volunteers to making the best use of all our resources, underpinned by a con"nuous culture of learning, growth and openness, enables us to deliver excellent services

V/=S63;'P67N'N/18!

R$&0)",X1&02O)Q+')0QX")$%)&Q)"1-L")X1&$"&%)1()^1,$L$"%)%+XXQ'&"()-2)5'""&QX%)&Q)L$]")1()($")U"LL_%

&<L726363;'2'.<57<=8'/K'7=<L7O'P2=07N'239'L2K874!

6]"'2Q")VQ,$#)$&Q)VQ&1V&)U$&0)5'""&QX%)$%)&'"1&"()U$&0)VQ,X1%%$QO)V1'")1()'"%X"V&_%

R")]1L+")&0")%&'"#&0)&01&)VQ,"%)U$&0)$VL+%$QO)1()U")U"LVQ,")"a+1L$&2)1()($]"'%$&2)1%)1)V'"1&$]")QXXQ'&+$&2)&Q) ",-'1V"O)'"%XQ()&Q)1()-")'"L"]1&)&Q)Q+')LQV1L)VQ,,+$&2_%

81#");%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

$:T8.76M8L'239'2.76M6768L',./3763<89>!

/6!&7=278;68L'K/='2.N68M63;'/:T8.76M8L!

R")L1+V0"()Q+')"U)&0'"":2"1')%&'1&"#2O)/'1^&$#)&0")C+&+'")Q^)JQ%X$V")/1'"O)$)DX'$L);A;Z_%

50$%)XL1)U$LL)0"LX)+%)"bX1()Q+')%X"V$1L$%&)VQ,,+$&2:-1%"()"(:Q^:L$^")V1'")^Q')X"QXL")1V'Q%%)V"&'1L)1()%Q+&0"'*) E"'-2%0$'"_%

E",1()^Q')"(:Q^:L$^")V1'")$%)'$%$#O)1()X'"%%+'")Q)-Q&0)-"(("()0Q%X$V")1()4J7)%"']$V"%)VQ&$+"%)&Q)#'QU_))3+')"U) %&'1&"#2)%"&%)Q+&)1)VL"1')1()%+%&1$1-L")U12)^Q')Q+')Q:-"(("(),Q("L)&Q)%+XXQ'&)LQV1L)0"1L&0)1()V1'")%2%&",%O)U0$L") "%+'$#)X"QXL")'"V"$]")&0")VQ,X1%%$Q*1&"O)"bX"'&)V1'")&0"2)("%"']"_%

3]"')&0")"b&)&0'"")2"1'%O)U")U$LL)%&'"#&0")1()("]"LQX)Q+')VL$*$V1L)%"']$V"%)-2.%

3+')1XX'Q1V0)$%)("%$#"()&Q)VQ,XL","&)&0")"]QL]$#)0Q%X$V")L1(%V1X")Q^^"'$#)1),Q("'O)^$1V$1LL2)%+%&1$1-L"),Q("L) &01&)1L$#%)U$&0)X1&$"&)X'"^"'"V"%)1()%+XXQ'&%)LQ#:&"',)'"%$L$"*V"_%

%45%&'2'&'"#1/06%+'"2'()/78"%&'2"#!

The Trustees have referred to the guidance contained in the Charity Commission’s general guidance on public benefit. They are confident that the aims and objec"ves of the charity as manifested in the services it offers, both provide a public benefit and enhance the lives of the people who use the services. More informa"on on how the charity has provided public benefit can be found in the achievements and performances sec"on of this report.

81#")<%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)

Y/345G4K6E[!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

$:T8.76M8L'239'2.76M6768L',./3763<89>!

78!U/5<3788=L!

In March, alongside communica"ons to staff, we held a series of in-person and online events to launch our three-year strategy, Cra$ing the Future of Hospice Care, to our volunteers. The events were well a%ended, genera"ng valuable feedback and strong support for our future plans and ambi"ons.

As of 14 August 2026, Treetops benefits from the support of 611 ac"ve volunteers, with more than 450 contribu"ng within our retail opera"on. Our shops con"nue to be a focal point within their local communi"es, a%rac"ng both volunteers and dona"ons while raising awareness of the charity and its work.

Our Gardening Team extended its offer to host the local Britain in Bloom Awards and have applied to rejoin the Open Garden Scheme. These ini"a"ves will welcome visitors to our beau"ful grounds, showcasing the care and dedica"on of the team while providing opportuni"es for people to learn more about Treetops and the services we provide. Regular collabora"on between the Gardening and Fundraising teams con"nues to generate new ideas to increase income, strengthen community engagement and promote the work of the hospice.

Counselling and Emo"onal Support con"nues to a%ract volunteers and students from across the UK, including interna"onal students. The service is recognised as a centre of excellence for bereavement and loss counselling, delivered from a traumainformed perspec"ve. Many students who train with us choose to remain as volunteers following qualifica"on, alongside experienced prac""oners working in private prac"ce who value the high-quality supervision, professional support and networking opportuni"es offered by the Treetops team.

For volunteer complementary therapists, the service provides a unique opportunity to adapt and apply their exis"ng skills within the specialist context of life-limi"ng illness, end-of-life care, bereavement and loss. Through this work, therapists deepen their understanding of the complex emo"onal and physical needs of those affected, enhancing their prac"ce within this important field.

Our annual volunteer recogni"on event, held during Na"onal Volunteers' Week, was a great success. Volunteers enjoyed a wonderful a$ernoon including food generously donated by The Harrington Arms, Thulston, and entertainment provided by a local male voice choir. The event was a fi&ng opportunity to celebrate and thank volunteers for the invaluable contribu"on they make to Treetops.

We recognise the importance of crea"ng a warm and welcoming environment for everyone who visits Treetops. Our volunteer recep"onists and Meet and Greet team play a vital role in ensuring visitors receive a posi"ve experience from the moment they arrive.

Volunteers suppor"ng our community bereavement hubs provide a compassionate and welcoming presence for those coping with grief and loss. As part of a dedicated team, they offer a listening ear, help a%endees feel comfortable and supported, and play an important role in crea"ng safe spaces where people can connect with others who have experienced bereavement. Through their commitment, these volunteers help extend the reach of Treetops' bereavement support within local communi"es, ensuring people receive support when they need it most.

Volunteers suppor"ng our on-site cafés also contribute to the welcoming environment that is highly valued by pa"ents, families and visitors alike.

Treetops could not deliver the breadth and quality of services we provide without the "me, dedica"on and exper"se of our volunteers. Their contribu"on is fundamental to our success, and we remain deeply grateful to everyone who generously gives their "me, energy and skills in support of our pa"ents, families and communi"es.

81#")=%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[% !"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

Achievements and Performance

!"]$"U )Q ^ )1 V&$]$&$"%

8'Q]$%$Q* )Q ^ )/ 1'"

50")0Q%X$V")L1%&)01()1)^+LL)Q%$&")$%X"V&$Q)-2)&0")/1'")f+1L$&2)/Q,,$%%$Q)Y/f/[)$)DX'$L);A9Z_)50")^$1L)'"XQ'&)1U1'("() &0")'1&$#)Q^)“NQQ(”)1V'Q%%)&0")^$]")(Q,1$%)Q^)71^"O)6^^"V&$]"O)/1'$#O)!"%XQ%$]")1()R"LL)I"(_)50")'"XQ'&)V1)-")^Q+()Q) -Q&0)&0")5'""&QX%)1*()/f/)U"-%$&"%_)%

/f/)01%)'"VQ^$#+'"()$&%)'"#+L1&Q'2)X'QV"%%)&Q)Q")Q^)Q#Q$#),Q$&Q'$#)+%$#)1)]1'$"&2)Q^)$^Q',1&$Q_)D%%"%%,"&)$%)Q&) &$"()&Q)%"&)(1&"%)Q')('$]")-2)1)X'"]$Q+%)'1&$#_)G&)$%)^QV+%"()Q)&0")^$]")W"2)a+"%&$Q%O)+("'X$"()-2)a+1L$&2)%&1&","&%_))% 50"2)%"&)VL"1')"bX"V&1&$Q%)Q^)X'Q]$("'%O)-1%"()Q)X"QXL"’%)"bX"'$"V"%)1()&0")%&1(1'(%)Q^)V1'")&0"2)"bX"V&_)%

/f/)#1&0"')$^Q',1&$Q)^'Q,)1)U$(")'1#")Q^)%Q+'V"%)1()'"]$"U$#)&0$%)$)'"L1&$Q)&Q)(1&1)0"L()-2)&0")/f/)'"#$%&'1&$Q)1() “ ” '1&$#%)$^Q',1&$Q)50$%)0"LX%)&0",)("&"',$")Q+')Q#Q$#)'1&$#))D%)1)'"%+L&O)&0")0Q%X$V")VQ&$+"%)&Q)-")'1&"()1%) NQQ( _%

The priori!es that we set for 2025/26

1 – Wellbeing Service

Our Wellbeing Service is designed to provide responsive advice and support to individuals, families and loved ones from the point of diagnosis, through periods of ill health and deteriora"on into more suppor"ve care as needs become increasingly complex. Throughout the year, the service con"nued to focus on enablement, emo"onal wellbeing, peer support and prac"cal advice, helping people to access the right support at the right "me in a way that promotes independence and improves quality of life.

At the start of the year, a reconfigura"on of the staff team led to a more structured programme of peer support sessions for pa"ents and clients. This change enabled the service to place greater emphasis on planned group ac"vi"es, shared learning and social connec"on, recognising the value of peer rela"onships in helping people adjust to life-limi"ng illness and bereavement.

Within this model, the Wellbeing Space priori"sed the weekly Support and Informa"on Café as the main route by which people newly diagnosed with a life-limi"ng illness or newly bereaved came into the hospice for advice, informa"on and support. The café has become an important early access point, offering a warm and welcoming environment where people can feel heard, receive guidance, plan ahead and connect with wider services available through the hospice.

Alongside this, strong collabora"ve rela"onships con"nued to grow with both the Hun"ngton’s Disease Associa"on and the MND charity, providing monthly support groups offering vital support to local people living with these condi"ons. These partnerships strengthened the hospice’s ability to respond to diagnosis specific need and created addi"onal opportuni"es for informa"on sharing, peer connec"on and specialist support.

The weekly Tears to Laughter bereavement support group con"nued to grow over the year, demonstra"ng the value of accessible peer and volunteer led support for people who are grieving. Building on the success of this format, a number of community bereavement hubs were also established during the year across the locality, enabling support to be offered closer to people’s homes and helping to widen access.

The occupa"onal therapy programme, with its focus on rehabilita"on and enablement, also con"nued to establish. This work aims to support people to maintain func"on, adapt to change, and maximise independence for as long as possible, contribu"ng to the wider aim of helping individuals live as fully as they can despite the impact of advancing illness.

Page)B%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

DV0$"]","&% )1 ( )8 "'^Q',1*V" ,./3763<89>!

5Q) %+XXQ'&) &0$%) "]QL]$#) X'Q#'1,,"O) ",X01%$%) U1%) 1L%Q) XL1V"() Q) "^^"V&$]") ]QL+&""') '"V'+$&,"&O) &'1$$#) 1() ("]"LQX,"&) HQL+&""'%) XL12) 1) $,XQ'&1&) 'QL") $) %+%&1$$#) 1V&$]$&2) 1V'Q%%) &0") R"LL-"$#) 7X1V"O) VQ&'$-+&$#) &Q) &0") U"LVQ,$#)1&,Q%X0"'")Q^)&0")V1^é)1()%+XXQ'&$#)&0")("L$]"'2)Q^)#'Q+X%)1*()X""':-1%"()1V&$]$&$"%%

E+'$#)&0")2"1'O)1)("V$%$Q)U1%),1(")&Q)VQ,-$")&0")R"LL-"$#)1&)JQ,")'"%X$&")%+XXQ'&)%"']$V")$&Q)&0")JQ%X$V")1&)JQ,") %"']$V")1()&Q)%01'X")&0")^QV+%)Q^)V1'")X'Q]$%$Q)&QU1'(%)X"QXL")$)&0")L1%&)U""W%)Q^)L$^"_)50$%)'"^L"V&"()&0")$V'"1%$#) (",1()^Q'),Q'")$&"%$]")"()Q^)L$^")V1'")1&)0Q,")1()&0")""()&Q)"%+'")1]1$L1-L")'"%Q+'V"%)U"'")($'"V&"()&QU1'(%)&0Q%") U$&0)&0")#'"1&"%&)L"]"L)Q^)VL$$V1L)""(_%

D%)1)'"%+L&O)&0")",X01%$%),Q]"()1U12)^'Q,)1)-'Q1("')'"%X$&")Q^^"')1()&QU1'(%)%+XXQ'&$#)&0Q%")$)&0")^$1L)U""W%)Q^)L$^"O) U0$L")VQ&$+$#)&Q)X'Q]$(")X"'%Q1L$%"(O)0QL$%&$V)V1'")$)&0")0Q,"_)50$%)$VL+("()+'%$#)$&"']"&$Q%O)",Q&$Q1L)%+XXQ'&O) ^+&+'")V1'")XL1$#)1()%+XXQ'&)&Q)0"LX)X"QXL")'",1$)$)&0"$')X'"^"''"()XL1V")Q^)V1'")1*()("1&0)U0"'"]"')XQ%%$-L"_%

51W")&Q#"&0"'O)&0"%")V01#"%)'"^L"V&)1)2"1')Q^)&'1%$&$Q)1()'"^QV+%)^Q')&0")R"LL-"$#)7"']$V"O)U$&0)1)%&'Q#"')",X01%$%) Q) %&'+V&+'"() X""') %+XXQ'&O) "1'L$"') 1VV"%%) &Q) 1(]$V") 1() $^Q',1&$QO) VQ,,+$&2) X1'&"'%0$X) UQ'W$#O) '"01-$L$&1&$QO) ]QL+&""')("]"LQX,"&)1()&1'#"&"()V1'")^Q')&0Q%")U$&0)&0")#'"1&"%&)*""(_%

; – )J Q%X$V" )1 & )J Q,"

50$%)2"1')%1U)1Q&0"')VQ%$%&"&)2"1')Q^)1V&$]$&2)1V'Q%%)&0")JQ%X$V")1&)JQ,")%"']$V"O)U$&0)%&1^^)VQ&$+$#)&Q)X'Q]$(")0$#0) a+1L$&2)V1'")1()%+XXQ'&)&Q)X1&$"&%O)^1,$L$"%)1()V1'"'%)(+'$#)&0")L1%&)(12%)1()0Q+'%)Q^)L$^"_)50")%"']$V")'",1$%)1)]$&1L)X1'&) Q^)&0")0Q%X$V")Q^^"'O)"1-L$#)X"QXL")&Q)-")V1'"()^Q')1&)0Q,")1&)&0")"()Q^)L$^")1()X'Q]$($#)'"1%%+'1V")1()%W$LL"()%+XXQ'&) 1&)1)&$,")Q^)%$#$^$V1&)""(_%

E",1()^Q')JQ%X$V")1&)JQ,")'",1$%)0$#0)1(O)1%)1)'"%+L&O)&0")%"']$V")VQ&$+"%)&Q)X'$Q'$&$%")&0Q%")U$&0)&0")0$#0"%&)L"]"L)Q^) ""()GV'"1%$#L2O)X1&$"&%)1'")'"^"''"()L1&"')$)&0")VQ+'%")Q^)&0"$')$LL"%%)1()'"a+$'"),Q'")$&"%$]")%+XXQ'&)Q]"')1)%0Q'&"' X"'$Q()Q^)&$,")50$%),"1%)&0")&"1,),+%&)^QV+%)1]1$L1-L")V1X1V$&2)Q)&0Q%")U0Q)1'")$)#'"1&"%&)""()Q^)+'#"&)"()Q^)L$^") V1'"_%

50")!Q1,$#)4+'%")7"']$V")01%)VQ&$+"()&Q)#'QU)1()'",1$%)$)0$#0)(",1(O)'"^L"V&$#)&0")]1L+")Q^)1)^L"b$-L")Q]"'$#0&) '"%XQ%") &01&) V1) X'Q]$(") &$,"L2) %+XXQ'&) 1V'Q%%) &0") VQ,,+$&2_) !Q1,$#) +'%"%) Q^^"') +'#"&) %2,X&Q,) ,11#","&O) ,"($V1&$Q)1(,$$%&'1&$QO)X"'%Q1L)V1'"O)X%2V0QLQ#$V1L)%+XXQ'&)1()]"'$^$V1&$Q)Q^)("1&0O)0"LX$#)&Q)1]Q$()+"V"%%1'2) 0Q%X$&1L)1&&"(1V")1()%+XXQ'&$#)X"QXL")&Q)'",1$)$)&0"$')+%+1L)XL1V")Q^)V1'"_%

G)Q'("')&Q)1L$#)&0")%"']$V")U$&0)Q&0"')0Q%X$V")X'Q]$("'%O)JQ%X$V")1&)JQ,")1L%Q)&'1%$&$Q"()&0$%)2"1')&Q)1VV"X&$#)($'"V&) '"^"''1L%_)50$%)01%)QX""()+X)1VV"%%)&Q)&0")%"']$V")1()V'"1&"()1),Q'")'"%XQ%$]")'Q+&")$&Q)V1'"O)"1-L$#)X1&$"&%)1() X'Q^"%%$Q1L%)&Q)VQ"V&),Q'")a+$VWL2)U$&0)&0")%+XXQ'&)&0"2)""(_)50")&"1,)1L%Q)UQ'W"()VLQ%"L2)U$&0)E"'-2%0$'")J"1L&0) K$&"()YEJK[O)&0")%&1&+&Q'2)Q+&)Q^)0Q+'%)X'Q]$("'O)&Q)"%&1-L$%0)1)%&'Q#)UQ'W$#)'"L1&$Q%0$X)1()%+XXQ'&)&0")VQQ'($1&"() ,11#","&)Q^)X1&$"&)V1'")50$%)01%)UQ'W"()U"LL)1()01%)%&'"#&0""()VQLL1-Q'1&$Q)1V'Q%%)%"']$V"%O)0"LX$#)&Q)"%+'") X1&$"&%)'"V"$]")&$,"L2)1()eQ$"()+X)%+XXQ'&)Q+&)Q^)0Q+'%_)DLQ#%$(")&0"%")("]"LQX,"&%O)&0")&"1,)01%)VQ&$+"()&Q) %&'"#&0")(QV+,"&1&$QO)V1'")VQQ'($1&$Q)1()%"']$V")'"%XQ%$]""%%)$)Q'("')&Q),""&)#'QU$#)(",1*()1%)"^^"V&$]"L2)1%) XQ%%$-L"%

81#")Z%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>

\ ] .<CD=44@<E=97 %. <CC8E@9@74 %S <>8E9773 %^ 7B3@7E?@EV

The Befriending Service con"nued to make a meaningful difference to the lives of those it supports, par"cularly individuals living in more deprived communi"es who are at greater risk of social isola"on and reduced access to support networks.

Through structured volunteer recruitment, training and careful matching, the programme provides companionship for people affected by illness or bereavement. Addi"onal volunteers were recruited across the year and matched into befriending rela"onships with clients in need of regular contact and support. These rela"onships con"nue to offer valued companionship, helping to reduce isola"on, build confidence and improve wellbeing.

Consistently posi"ve feedback from clients and their families reflects the emo"onal and prac"cal value of the service, with many describing how regular contact has helped them feel less alone and more supported during difficult "mes.

The programme is now opera"ng at capacity within the available volunteer cohort and funding constraints, but it con"nues to provide trusted, consistent support through strong volunteer client rela"onships.

The Compassionate Communi"es team complements this direct support by contribu"ng to wider system efforts to build Compassionate Neighbourhoods across the ICB, while also delivering spiritual care across the organisa"on and leading reflec"ve events such as ‘Time to Remember’.

YE% >@E7% ;@96% 53779<D4% =CP@9@<E% 9<% @CD3<N7% 7EV=V7C7E9% ;@96% A<CC8E@9@74% 6@493@A=>F% 8E?7337D3747E97?% @E% <83% 473N@A742% 53779<D4%6=4%A<E9@E87?%9<%4937EV967E%96747%A<EE7A9@<E4R%

+83@EV%967%F7=32%48DD<39%;=4%D3<N@?7?%9%967%+73PF46@37%^=AU%=E?%/@E<3@9F%X96E@A%:^/XG%-<38C%9<%4937EV967E%7EV=V7C7E9% ;@96%8E?7337D3747E97?%A<CC8E@9@742%=E?%=%E8CP73%?R%56@4%;<3U%6=4%67>D7?%P8@>?%93849%=E?% 8E?7349=E?@EV2% =><EV4@?7% D=39E7346@D4% 48A6% =4% X37;=46% IA@=% 0374A3@P7342% ;6@A6% 6=N7% 48DD<397?% >>F% >7?% @E@9@=9@N74% @EA>8?@EV%967%?7N7><DC7E9%<B%967%^737=N7C7E9%_8PR%

= – )5 0"'1X"+&$V )7 "']$V"%

+7C=E?%B<3%A<8E47>>@EV%473N@A74%=A3<44%=>>%=V7%V3<8D4%A<E9@E874%9<%P7%6@V62%=E?%967%97=C%6=4%E<;%37=A67?%967%>@C@94%<B%;6=9% @9%A=E%BB73%;@96@E%7`@49@EV%374amp#56;amp#51;amp#65;amp#55;amp#52;amp#82;amp#37;amp#47;amp#61;amp#69;amp#61;amp#86;amp#64;amp#69;amp#86;amp#37;amp#57;amp#54;amp#64;amp#52;amp#37;7N7%B%?7C=E?%37W8@374%A=37B8%<N734@V69%=E?%D3@<3@9@4=9@<E2%P89%967%97=C% 37C=@E4%A<CC@997?%9<%D3N@?@EV%9@C7F2%A<CD=44@<E=97%93=8C=%@EB<3C7?%48DD<39%;6737N73%D44@P7R%

567%/%03<Q7A9%A<E9@E874%9<%8=P>7%V3<8D%P737=N7C7E9%48DD<39%9<%A6@>?37E%=E?%F<8EV%D772%D3<N@?@EV%=%4=B7%=E?% 48DD<39@N7%4D=A7%@E%;6@A6%967F%A=E%A<EE7A9%;@96%<96734%;6<%6=N7%6=?%4@C@>=3%7`D73@7EA74R%56@4%V3<8D%=DD3<=A6%37C=@E4%=E% @CD<39=E9%D=39%<B%967%;@?73%9673=D789@A%<BB732%A7C7E9@EV%@E?@N@?8=>%A<8E47>>@EVR%

567%.67796=C%.7E937%37B3746%@4%E<;%8E?73;=F%=E?%37D3747E94%=%C8A6]E77?7?%@EN749C7E9%@E%967%7EN@3<EC7E9%B3<C%;6@A6% 96@4%;3U%@4%?7@N737?R%56=EU4%9<%967%48DD<39%<B%967%A6=3@9F%.J)I_2%?74@VE%7`D739@47%=E?%374<83A74%6=N7%P77E%47A837?%9<% 48DD39%96@4%?7N7D@EV%9<%A37=97%=%C37%48@9=P7%=E?%;7>A<C@EV%4D=A7%B<3%A6@>?37E2%F<8EV%D77%=E?%B=C@>@74% =AA744@EV%967%473N@A7R%

567%97=C%A<E9@E874%9<%C=@E9=@E%@94%.7E937%A7>>7EA7%49=984%B<3%93=8C=]@EB<3C7?%A<8E47>>@EV%=E?%7C<9@<E=>%48DD<392% 37B>7A9@EV%@94%4849=@E7?%A<CC@9C7E9%9<%6@V6]W8=>@9F2%4D7A@=>@49%D3=A9@A7R%X?8A=9@<E%A<E9@E874%9<%V3<;%=><EV4@?7%96@42%;@96% ?7C=E?%B<3%498?7E9%D>=A7C7E94%7937C7>F%6@V6%=E?%@EA37=4@EV%@E973749%@E%=AA744%9<%93=@E@EV%B3%4A6<<>4%=E?%7973E=>% =V7EA@74R%56@4%V3<;@EV%=DD79@97%B<3%>7=3E@EV%37B>7A94%P<96%967%97=C’4%7D739@47%=E?%967%@EA37=4@EV%37A<VE@9@<E%<B%5377987?%4<83A7%B%4D7A@=@49%UE<;>7?V7%=E?%48DD<39R%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

81#")>%

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

B – 81LL$1&$]" )1 ( )6 ( )Q ^ )I $^" )/ 1'" )V QLL1-Q'1&$Q )U $&0 )& 0" )! "%$("&$1L )/ 1'" )J Q," )7 "V&Q'

50$%)2"1'O)&0")X'Qe"V&)VQ&$+"()&Q)%&'"#&0")X1LL$1&$]")1()"()Q^)L$^")V1'")1V'Q%%)&0")'"%$("&$1L)V1'")0Q,")%"V&Q')-2) VQ,-$$#)($'"V&)VL$$V1L)%+XXQ'&O)UQ'W^Q'V")("]"LQX,"&)1()X'1V&$V1L)a+1L$&2)$,X'Q]","&)1V&$]$&2_)G&%)("L$]"'2)01%)0"LX"() V1'")0Q,"%),Q]")&QU1'(%)1),Q'")X'Q1V&$]")1()XL1"()1XX'Q1V0)&Q)V1'"O)U0$L")1L%Q)%&'"#&0"$#)'"L1&$Q%0$X%)-"&U"") &0")0Q%X$V"O)V1'")0Q,"%)1()U$("')VQ,,+*$&2)%"']$V"%_%

E+'$#)&0")X'Qe"V&)&0")&"1,)"#1#"()1LL)9?)'"%$("&$1L)V1'")0Q,"%)$)6'"U1%0)1()"b&"("()$&%)'"1V0)-"2Q()&0")Q'$#$1L) %VQX"O)U$&0);;)0Q,"%)"#1#"()$)&Q&1L_)50$%)(",Q%&'1&"%)-Q&0)&0")L"]"L)Q^)+,"&)""()U$&0$)&0")%"V&Q')1()&0")]1L+") XL1V"()Q)&0")%+XXQ'&)Q^^"'"()M2)E"V",-"');A;BO)&0")X'Qe"V&)01()%+XXQ'&"()Z9<)'"%$("&%O)"bV""($#)$&%)Q'$#$1L)&1'#"&)1() %0QU$*#)&0")-'"1(&0)Q^)$&%)$,X1V&)1V'Q%%)&0")LQV1L$&2%

D),1eQ')1'"1)Q^)$,X1V&)01%)-"")UQ'W^Q'V")("]"LQX,"&)5'1$$#)1&&"(1V")%$#$^$V1&L2)"bV""("()"bX"V&1&$Q%O)U$&0)B=>) %&1^^)1&&"($#)"(+V1&$Q)%"%%$Q%)1#1$%&)1)&1'#"&)Q^)<AA)-2)P"1');)6]1L+1&$Q)(1&1)%0QU"()$V'"1%"()VQ^$("V")1,Q#) V1'")0Q,")%&1^^)$)'"VQ#$%$#)("&"'$Q'1&$QO)01]$#)VQ]"'%1&$Q%)1-Q+&)^+&+'")V1'")U$%0"%O)1()%+XXQ'&$#)X"QXL")1() ^1,$L$"%)1&)&0")"()Q^)L$^")50$%)$%)1)$,XQ'&1&),1'W"')Q^)$,X1V&O)1%)$&)'"^L"V&%)&0")("]"LQX,"&)Q^),Q'")%+%&1$1-L")%W$LL%)1() VQ^$("V")U$&0$)&0")V1'")0Q,")UQ'W^Q'V")$&%"L^%

50")X'Qe"V&)1L%Q)%+XXQ'&"(),"1$#^+L)$,X'Q]","&%)$)X'1V&$V")50")$&'Q(+V&$Q)Q^)X1LL$1&$]")V1'")'"#$%&"'%)$)9=)0Q,"%) 0"LX"()%0$^&)V1'")1U12)^'Q,)'"1V&$]")V'$%$%),11#","&)&QU1'(%)"1'L$"')$("&$^$V1&$QO)-"&&"')XL1$#)1(),Q'")VQQ'($1&"() %+XXQ'&)G)X1'1LL"LO)&0")E6IfKD)a+1L$&2)^'1,"UQ'W)U1%)1(1X&"()^Q')+%")U$&0$)'"%$("&$1L)V1'")0Q,"%O)V'"1&$#)1),Q'") '"1L$%&$V)1()1V0$"]1-L"),Q("L)^Q')a+1L$&2)$,X'Q]","&)$)&0$%)%"&&$#_%

DLQ#%$(") &0"%") 1V0$"]","&%O) &0") X'Qe"V&) 01%) #""'1&"() ]1L+1-L") L"1'$#_) E",1() ^Q') %+XXQ'&) "bV""("() V1X1V$&2O) X1'&$V+L1'L2)^'Q,)0Q,"%)Q+&%$(")&0")Q'$#$1L)&1'#"&)1'"1O)1()&0")&"1,)$("&$^$"()&01&)^'1$L&2)1LQ")U1%)Q&)1LU12%)1)'"L$1-L") U12)&Q)$("&$^2)X"QXL")"1'$#)&0")"()Q^)L$^"_)50")'"1L$&$"%)Q^)%&1^^$#)X'"%%+'"%)U$&0$)&0")%"V&Q')1L%Q)VQ&$+"()&Q)1^^"V&) &'1$$#) 1&&"(1V"O) U$&0) V1V"LL1&$Q%) '",1$$#) VQ,,Q) 50"%") $%$#0&%) 01]") -"") $,XQ'&1&) $) %01X$#) ^+&+'") 1XX'Q1V0"%)1()$("&$^2$#)U0"'"),Q("L%)Q^)%+XXQ'&)""()&Q)-")1(1X&"()&Q)'",1$)"^^"V&$]")1()%+%&1$1-L"%

DL&0Q+#0)&0")Q'$#$1L)("L$]"'2),Q("L)V1Q&)VQ&$+")$)^+LL)(+")&Q)^+($#)X'"%%+'"%O)&0")UQ'W)01%)L1$()%&'Q#)^Q+(1&$Q%) ^Q')LQ#"')&"',)$,X1V&)I"1'$#)^'Q,)&0")X'Qe"V&)$%)QU)-"$#)&1W")^Q'U1'()&0'Q+#0)&0")$&"#'1&$Q)U$&0)&0")E"'-2%0$'") DLL$1V")6()Q^)I$^")/1'")&QQLW$&O)V01,X$Q)"&UQ'W)1()U$("')&'1$$#)Q^^"'O)"%+'$#)&01&)&0")WQUL"(#"O)'"L1&$Q%0$X%)1() X'1V&$V")$,X'Q]","&%)"%&1-L$%0"()(+'$#)&0")&UQ)2"1')X'Qe"V&)VQ&$+")&Q)$^L+"*V")V1'"%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

81#")?%

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Z – /L$$V1L )f +1L$&2 )1 ( )6 (+V1&$Q*

50$%)2"1'O)U")01]")VQ&$+"()&Q)"]QL]")Q+')"(+V1&$Q)1()("]"LQX,"&)Q^^"'O)"01V$#)$&"'1L)%&1^^)("]"LQX,"&)U0$L") "b&"($#)&'1$$#)QXXQ'&+$&$"%)&Q)X1'&"'%)1V'Q%%)&0")U$("')0"1L&0V1'")%2%&",O)1LQ#)U$&0)",-'1V$#)X+-L$V)"(+V1&$Q)1() 1U1'""%%)50$%)^QV+%)01%)-"")Q)"%%"&$1L)&Q)'QL")VL$$V1L)%W$LL)("]"LQX,"&)1()V'"1&$#)-Q&0)1)^1V")&Q)^1V")1()QL$")Q^^"') U$&0)?@)VQ+'%"%)("L$]"'"()1()B9;)("L"#1&"%)&'1$"()Q]"')&0")2"1')%

!"1L51LW)–)N'QU&0O)6#1#","&O)1()41&$Q1L)!"VQ#$&$Q%

50")!"1L51LW)XL1&^Q',O)VQ:L$V"%"()U$&0)IQ+#0-Q'Q+#0)K$]"'%$&2O)01%)VQ&$+"()&Q)"bX1()U$&0)1)#'QU$#)1&$Q1L)X'Q^$L") 50$%)01%)-"")%+XXQ'&"()&0'Q+#0)VQ&'$-+&$Q%)&Q)W"2)1&$Q1L)VQ^"'"V"%O)X'"%"&$#)1&)-Q&0)JQ%X$V")KT)$)I$]"'XQQL)1() 7&'1&0V1''Q)JQ%X$V")41&$Q1L)/Q^"'"V")$)6($-+'#0O)^+'&0"')%&'"#&0"$#)Q+')'"X+&1&$Q)1()'"1V0%

D%)X1'&)Q^)Q+')VQ,,$&,"&)&Q)%1^"O)0$#0)a+1L$&2)$,XL","&1&$QO)1)VQ,X'"0"%$]")'"]$"U)Q^)1LL)'"#$%&"'"()!"1L51LW)^1V$L$&1&Q'%) 01%)&1W")XL1V")Q]"')&0")X1%&)9;),Q&0%)C1V$L$&1&Q'%)U"'")VQ&1V&"()&Q)VQ^$',)&0"$')VQ&$+"()"#1#","&O)U$LL$#"%%)&Q) '"&1$)1VV"%%O)1()1(0"'"V")&Q)&0")'"a+$'"()%1^"#+1'(%)1()%&1(1'(%_)R0"'")$($]$(+1L%)($()Q&)'"%XQ()&Q)X'Q,X&%O)1VV"%%) 01%)-"")1XX'QX'$1&"L2)'",Q]"(_)D%)1)'"%+L&O)&0")V+''"&)VQ0Q'&)'"X'"%"&%)1),Q'")1VV+'1&"O)1V&$]"L2)"#1#"(O)1()%1^"L2) #Q]"'"()^1V$L$&1&Q')-1%")50")2"1')VLQ%"()U$&0)<B;)'"#$%&"'"()+%"'%_%

5Q)%+XXQ'&)$,XL","&1&$Q)1()%01'"()L"1'$#O)a+1'&"'L2)!"1L51LW)/Q,,+$&2)Q^)8'1V&$V")%"%%$Q%)1'")QU)"%&1-L$%0"()/Q: ("%$#"() U$&0) +%"'%) 1() 1&&"("() -2) ^1V$L$&1&Q'%) 1&$Q1LL2O) &0"%") %"%%$Q%) Q^^"') 1) ]1L+1-L") ^Q'+,) ^Q') 1XXL$"() L"1'$#O) '"^L"V&$]")($%V+%%$QO)1()X""')%+XXQ'&O)U$&0)&QX$V%)%01X"()($'"V&L2)-2)+%"')*""(%

G,XQ'&1&L2O)5'""&QX%)01%)VQ&$+"()&Q)XL12)1)V"&'1L)L"1("'%0$X)'QL")$)&0")XL1&^Q',’%)("]"LQX,"&)1()%X'"1(O)X'Q]$($#) ,"&Q'%0$X)1()$,XL","&1&$Q)%+XXQ'&)&Q)&"1,%)$)6($-+'#0)1()4Q'&01,X&Q)(+'$#);A;BO)^+'&0"')%&'"#&0"$#)-Q&0) '"#$Q1L)1()1&$Q1L)$,X1V&_)%

3+')&0'"":&$"')VQ,,+$V1&$Q)%W$LL%)^'1,"UQ'W)'",1$%)1)VQ'"'%&Q")Q^)Q+')"(+V1&$Q)("L$]"'2O)&0$%)&$"'"()1XX'Q1V0)&Q) VQ,,+$V1&$Q)%W$LL%)$%)-+$L($#)VQ^$("*V")1V'Q%%)&0")UQ'W^Q'V".)%

5$"')9.)6%%"&$1L)/Q,,+$V1&$Q)7W$LL%) –)F1(1&Q'2)^Q')1LL)5'""&QX%)%&1^^)1()]QL+&""'%O)$)L$")U$&0)&0")E"'-2%0$'")G/M) “G*^Q',"()RQ'W^Q'V"”)%&'1&"#2_%

– 5$"');.)/Q+'1#"Q+%)/Q]"'%1&$Q%) )7+XXQ'&$#)0"1L&0V1'")X'Q^"%%$Q1L%)U$&0)%"%$&$]")VQ]"'%1&$Q%)1'Q+()+V"'&1$&2O) ^+&+'")V1'")XL1$#O)1()!"786/5)($%V+%%$Q*%_%

– 5$"')<.)D(]1V"()/Q,,+$V1&$Q)7W$LL%)5'1$$#)YD/75[) )E"L$]"'"()$:X"'%Q)U$&0)"bX"'&)^1V$L$&1&$Q)1()X'Q^"%%$Q1L)1V&Q') 'QL":XL12O)V'"1&$#)1)X%2V0QLQ#$V1LL2)%1^")%X1V")^Q')1XXL$"(O)&'1+,1:$^Q',"()L"1'$#_%

DV'Q%%) 1LL) &$"'%O) ("L"#1&") ^""(-1VW) 01%) -"") VQ%$%&"&L2) %&'Q#O) U$&0) "]1L+1&$Q%) (",Q%&'1&$#) ,1'W"() $V'"1%"%) $) VQ^$("V"O)VQ,X"&"V"O)1()$,X1V&)Q)X'1V&$V"_%

R")01]")-"")VQ,,$%%$Q$#)1V'Q%%)&0")%2%&",)^Q')U$(")!"786/5)D+&0Q'%0$X)&'1$$#)QL$"_)R")1'")1L%Q)"%&1-L$%0$#)&0") ^'"")U"-$1'%)&Q)%QV$1L)V1'")1()&0")X+-L$V)0"1&0)1XX'Q1V0)&Q)^+&+'")V1'")XL1$#)O)"b1,XL"%)Q^)I1%&)E12%)F1&&"'O)4Q)M1''$"'%) J"'")1()F2&0)-+%&$#)Q)L$*")UQ'W%0QX%_%

R") U"'") 1L%Q) X'Q+() &Q) -") X1'&) Q^) &0") "U) &0'"") G/M) /L+%&"') 6(+V1&$Q) ,""&$#%) 1V'Q%%) E"'-2%0$'"O) I$VQL%0$'") 1() 4Q&&$#01,%0$'"O)5'""&QX%`)L"1("'%0$X)$)&0$%)$$&$1&$]")01%)%$#$^$V1&L2)"01V"()Q+')'"#$Q1L)X'Q^$L")1()$^L+"V"_)R")1'") UQ'W$#)1V'Q%%)&0")<)%2%&",%)("]"LQX$#)($%V+%%$Q%)1'Q+()&0")6%%"&$1L)&Q)!QL")5'1$$#)X1%%XQ'&)O)1(),Q'")LQV1LL2O)Q+') %&1^^)VL$$V1L)VQ,X"&"V2)#+$(1V")01%)-""*)("]"LQX"(_%

81#")@%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

!"]$"U )Q ^ )7 "']$V"%

C'Q,)9)DX'$L);A;B)&Q)<9)F1'V0);A;ZO)5'""&QX%)JQ%X$V")U1%)VQ,,$%%$Q"()&Q)X'Q]$(")&0")R"LL-"$#)7"']$V"O)JQ%X$V")1&)JQ,") 1()/Q+%"LL$#)1()6,Q&$Q1L)7+XXQ'&)^Q')&0Q%")U0Q)01]")-"")-"'"1]"()1()&0Q%")^1V$#O)Q')%+XXQ'&$#)%Q,"Q")U0Q)01%) -"")($1#Q%"()U$&0O)1)L$^":L$,$&$#)$LL"%%)-2)&0")E"'-2)1()E"'-2%0$'")G&"#'1&"()/1'")MQ1'(_)%

5'""&QX%)JQ%X$V")'1$%"%)?Ag)Q^)&0")^+($#)^Q')&0"%")%"']$V"%)&0'Q+#0)'"&1$L)Q+&L"&%O)LQ&&"'2)1()^+('1$%$#_)50")'",1$$#) ;Ag)VQ,"%)^'Q,)&0")4J7)]$1)&0")1-Q]")G/M%)&0'Q+#0)1)-LQVW)#'1&)VQ*&'1V&_)%

5'""&QX%)JQ%X$V")1L%Q)Q^^"'%)1)7+XXQ'&)1()G^Q',1&$Q)7"']$V"O)/Q,XL","&1'2)50"'1X2)1()M"^'$"($#)c)/Q,X1%%$Q1&") /Q,,+$&$"%) 7"']$V"O) 1LQ#) U$&0) Q+') H$'&+1L) R1'() ,Q("L) %+XXQ'&$#) !"%$("&$1L) /1'") JQ,"%) R") VQ&$+") &Q) 0Q%&) 1) Q+&X1&$"&)VL$$V)^Q')&0")K$]"'%$&2)JQ%X$&1L)E"'-2)1()M+'&Q)4J7)5'+%&)50")VL$$V)$%)'+)-2)1)7X"V$1L$%&)81LL$1&$]")/1'") /Q%+L&1&O)%+XXQ'&"()-2)0Q%&)]QL+&""'%_)50")VL$$V)%+XXQ'&%)X1&$"&%)U$&0)X1LL$1&$]")V1'")""(%_%

3+')/L$$V1L)7"']$V"%)1'")#Q]"'"()-2)&0")/L$$V1L)7+-:VQ,,$&&"")Q^)&0")MQ1'()Q^)5'+%&""%O)U0Q),""&)a+1'&"'L2)1()'"V"$]") $($]$(+1L)%"']$V")'"XQ'&%O)U0$V0)"1-L"%)&0",)&Q)'"]$"U)&0"),11#","&)1()a+1L$&2)Q^)V1'")X'Q]$("()-2)&0")0Q%X$V"_)50") '"XQ'&%)1'")&0")%+-,$&&"()&Q)&0")U0QL")MQ1'()Q^)5'+%&""%)1&)&0"$'),""&$*#%_%

81'&$V$X1&$Q )$ * )/ L$$V1L )D +($&%

E+'$#);A;Bc;ZO)5'""&QX%)JQ%X$V")($()Q&)X1'&$V$X1&")$)12)1&$Q1L)Q')LQV1L)VL$*$V1L)1+($&%_%

50")0Q%X$V")($()0QU"]"')VQ,XL"&")$&"'1L)1+($&)1()a+1L$&2)V0"VW%)$)L$")U$&0)$&%)XQL$V$"%)1()X'QV"(+'"%_))%

50")'"#+L1&$Q%)'"a+$'")X'Q]$("'%)&Q)VQ,XL"&")&0")^QLLQU$#)&UQ)%&1&","*&%.%

!"%"1'V0

E+'$#);A;Bc;ZO)&0")JQ%X$V")U1%)Q&)$]QL]"()$)1*2)'"%"1'V0)X'Qe"V&%_))%

4J7 )f +1L$&2 )G ,X'Q]","& )1 ( )G *Q]1&$Q )N Q1L%

5'""&QX%)JQ%X$V")01%)a+1L$&2)'"a+$'","&%)%"&)-2)&0")E"'-2)1()E"'-2%0$'")G*&"#'1&"()/1'")MQ1'(.%

81#")9A%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

f+1L$&2 )3 ]"']$"U

DV&$]$&2)(1&1)1V'Q%%)&0")2"1')'"]"1L%)&0")^QLLQU$#)&'"(%_%

R"LL-"$*# )7 "']$V"

50")R"LL-"$#)7"']$V")%+XXQ'&"()B 9? )X "QXL" )Q ]"'1LL )(+'$#)&0")2"1'O)X'Q]$($#)1)-'Q1()'1#")Q^)1(]$V"O)",Q&$Q1L)U"LL-"$#) %+XXQ'&O)X""')VQ"V&$QO)X'1V&$V1L)$^Q',1&$QO)"1-L","&)1()V1'")50")%"']$V")VQ&$+"()&Q)Q^^"')-Q&0)0Q%X$V")-1%"()1() 0Q,")-1%"()%+XXQ'&O)U$&0)1V&$]$&2)("L$]"'"()&0'Q+#0)&0")R"LL-"$#)7X1V"O)R"LL-"$#)1&)JQ,")1()1)'1#")Q^)VQ($&$Q: %X"V$^$V)1()-"'"1]","*&:^QV+%"()#'Q+X%%

R"LL-"$#)1&)JQ,")(1&1)VQ]"'%)1)%$b:,Q&0)X"'$Q()QL2O)1%)&0")%"']$V")U1%)'"VQ^$#+'"()(+'$#)&0")2"1')1()$VQ'XQ'1&"() $&Q)&0")JQ%X$V")1&)JQ,")%"']$V")50$%)V01#")%+XXQ'&"()1)VL"1'"')^QV+%)Q)X"QXL")U$&0),Q'")$&"%$]")V1'")""(%)U0$L") X'"%"']$#)&0")0QL$%&$V)X'$V$XL"%)Q^)&0")U$("')R"LL-"$#)Q^^"'%

R$&0$)&0")R"LL-"$#)7X1V"O); B? )X "QXL"c'"^"''1L% )U"'")%+XXQ'&"()(+'$#)&0")2"1'_)50$%)"a+1&"()&Q)< O9>? )0 Q+'% )Q ^ )V 1'" )1() <OA?@ )% +XXQ'& )V Q&1V&% O)(",Q%&'1&$#)&0")VQ&$+"()]1L+")Q^)0Q%X$V")-1%"()%+XXQ'&)^Q')X"QXL")L$]$#)U$&0)L$^":L$,$&$#)$LL"%%O) &0Q%")U0Q)1'")-"'"1]"(O)1()^1,$L$"%)%""W$#)"1'L2)1(]$V")1()VQ"V&$Q_%

CQ')&0")%$b),Q&0%)'"XQ'&"(O)R"LL-"$#)1&)JQ,")%+XXQ'&"()< 9= )X "QXL" O)'"V"$]"(); A? )' "^"''1L% )1()VQ,XL"&"()> > 1%%"%%,"&% )50")&"1,)("L$]"'"(); OBA; )0 Q+'% )Q ^ )V 1'" )1()'"VQ'("()> O;>> )V Q&1V&% O)'"^L"V&$#)&0")$&"%$&2)1()X"'%Q1L$%"() 1&+'")Q^)%+XXQ'&)X'Q]$("()&Q)X"QXL")$)&0"$')QU)0Q,"%%

50")(1&1)-"LQU)V1X&+'"%)&0")'1#")Q^)1V&$]$&$"%)X'Q]$("()1V'Q%%)&0")2"1')1()&0")&'1%$&$Q)$)%"']$V"),Q("LO)$VL+($#)&0")%$b: ,Q&0)'"XQ'&$#)X"'$Q()^Q')R"LL-"$#)1&)JQ,"_%

81#")99%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Ac!vity 2024/25 2025/26 Comments
Ac!vity Ac!vity
Number of individual pa"ents
supported in the Wellbeing Space
264 258 The Wellbeing Space supported 258
people/referrals during the year as the
service con"nued to focus on advice,
enablement, peer support and group-based
ac"vity.
This ac"vity forms part of the overall
Wellbeing Service total of 518 people
supported.
Number of individual support
contacts delivered across the year
within the Wellbeing Space.
5,220 3,089 This is a drop of 2,131 contacts, a 41%
reduc"on in ac"vity.
Hours of care delivered across the
programme
Included ac"vi"es:
·
SPRING programme
·
Mollie’s MND Support
group
·
Hun"ngton’s Disease
Support Group
·
Support and Informa"on
Café
·
Tears to Laughter group
4,560 3,178 Hours
of
care
delivered
across
the
programme reduced from 4,560 to 3,178, a
decrease of 1,382 hours, represen"ng a 30%
reduc"on on the previous year.
Number of Individuals supported
at Home by the Wellbeing at
Home Service care visits
477 314 Wellbeing at Home supported 314 people
during a three-month repor"ng period only.
During this three-month period, 208
referrals were received and 77 assessments
were completed.

81#")9;%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Ac!vity 2024/25 2025/26 Comments
Ac!vity Ac!vity
Number of hours of care
delivered by the Wellbeing at
Home Service
4,391 hours of care 2,502 hours of care Wellbeing at Home delivered 2,502 hours
of care during the six-month repor"ng
period.
The service also recorded 7,277 contacts,
refec"ng the level of coordina"on and
direct support provided in the home
environment.

Over the year, we con"nued to monitor ac"vity levels and seek the views of a%endees to our Wellbeing services. Feedback showed that, while people valued the support they received from Treetops, many preferred to access support directly within their own communi"es, reducing the need to travel and enabling them to engage in everyday ac"vi"es closer to home.

This feedback has helped shape the ongoing review and remodelling of the service, ensuring that future provision remains responsive to local need, supports independence and reflects how people want to access wellbeing support.

Hospice at Home Service

The Hospice at Home service consists of the Roaming Nurse Service which provides a flexible response to care needs across the night shi$ alongside the provision of 1:1 nursing support for nine hours throughout the night.

The Hospice at Home service supported 1,161 people during the year and received 1,222 referrals . Across planned Hospice at Home care, the Roaming Nurse Service, and care planning and triage, combined reported Hospice at Home ac"vity totalled 18,785 hours .

Planned Hospice at Home delivered 13,321 hours of care and 12,836 care contacts , with an average of 3.03 full-night shi"s per pa!ent . The service enabled 98% of people to die in their preferred place of care, which was home.

The Roaming Nurse Service received 2,184 telephone calls , 1,503 home visits and 4,974 hours of care . A further 490 hours were delivered through care planning and triage, suppor"ng safe coordina"on, priori"sa"on and "mely response across the service.

The data below captures the range of ac"vi"es provided across the year.

81#")9<%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Activity 2024/25 2025/26 Comment
Activity Activity
Pa"ent Numbers
All Hospice at Home
Services
1,122 1,161 The Hospice at Home service supported 1,161
people during the year and received 1,222 referrals.
This refects sustained demand for end of life care at
home and the con"nued need to priori"se people
with the highest level of need.
Points of Contact
All Hospice at Home
Services
25,700 27,553 Points of contact increased from 25,700 to 27,553,
an increase of 1,853 contacts, represen"ng a 7.2%
increase on the previous year.
Number of hours of care 18,719 19,690 Hours of care increased from 18,719 to 19,690, an
increase of 971 hours, represen"ng a 5.2% increase
on the previous year.

The Hospice at Home team has sustained its excep"onally high standards of care this year, despite con"nual capacity pressures. Increasingly, pa"ents are referred at a later, more acute stage of illness, so the service must focus on those in greatest need. As a result, only red- and amber-rated pa"ents under our traffic-light criteria are now rou"nely scheduled.

Green-rated pa"ents are only accepted when essen"al to protect a carer’s health and wellbeing.

Because people are generally more poorly on admission, they move through the service more rapidly: support now typically lasts days rather than weeks, with an average commitment of 3.03 full-night shi$s per pa"ent.

Alongside this, demand for the Roaming Nurse Service has con"nued to grow, with many families now choosing it as their preferred model of care.

The Hospice at Home Service enabled 98% of individuals to die in their preferred place of care, which was home.

81#")9=%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Therapeu!c Services

Our commissioned Bereavement Support Service in Derbyshire is open to referrals from anyone in the community, regardless of any prior connec"on to Treetops Hospice.

Our Life-Limi"ng Illness (LLI) Counselling support service is not only for people who are accessing end-of-life care at the hospice but is for anyone in our community facing a life-limi"ng illness or their family.

Due to increasing demand, the team now priori"ses the most complex cases, signpos"ng individuals with less complex needs to alterna"ve support services when appropriate. For those who do not require one-to-one counselling, our Tears to Laughter and bereavement hub peer support groups offer an addi"onal wellbeing pathway.

Over the past year, Complementary Therapy (CT) capacity has become more consistent, suppor"ng more stable service delivery. Alongside this, the team has been developing volunteer opportuni"es within the service to further strengthen the CT offer and support future capacity.

Over the course of the year, Therapeu"c Services supported 702 people through counselling, emo"onal support, nontalking therapy and Complementary Therapy pathways.

5,122 counselling, emo!onal support and non-talking therapy sessions were delivered across adult counselling, children and young people’s counselling and the Molli"am non-talking therapy project.

Adult Bereavement and LLI Service Data

2024/25 2025/26
Sessions Sessions Percentage change
Total number of counselling sessions (including
assessments)
3,421 3,495 2.2% increase

81#")9B%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Children and Families Bereavement Service Data

2024/25 2025/26
Sessions Sessions Percentage change
Total number of counselling sessions 1,581 1,450 8.3% decrease

The wider therapeu"c offer also included the Molli"am non-talking therapy project, which supported 20 children , completed 30 assessments , delivered 24 group sessions and provided 177 delivery hours .

Treetops Counselling and Emo"onal Support Services con"nue to monitor care delivery against the Bereavement Care Service Standards na"onal evalua"on tool, endorsed by the Na"onal Bereavement Alliance, to which Treetops Hospice is affiliated. This sets three levels of achievement within seven separate standards. These are Planning, Awareness and Access, Assessment, Support and Supervision, Educa"on and Training, Resources, and Monitoring and Evalua"on.

Our team are dedicated to working to this standard and we are confident that we con"nue to achieve the highest level across all seven of the standards.

Complementary Therapy Service Data

This service is not a commissioned service. During the year, Complementary Therapy supported 58 adults and 21 children and young people . Adult ac"vity included 95 referrals , 76 assessments and 286 sessions . Children and young people’s ac"vity included 27 referrals , 23 assessments and 88 sessions .

Compassionate Community Befriending Service

The year saw con"nued uptake of the Befriending Service suppor"ng people in their own homes who are socially isolated due to their ill health or following a bereavement.

This is not a commissioned service and is now fully funded by the charity.

Over the year, the Befriending Service supported 20 people through volunteer befriending. The service delivered 238 visits , providing 451 hours of befriending support.

The service received 5 referrals during the year.

81#")9Z%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>

What others say about us

Care Quality Commission

Treetops Hospice is registered with, and regulated by, the Care Quality Commission in accordance with the Health & Social Care Act 2008.

Our most recent inspec"on report dated 7 April 2016 is available on the CQC website and finds us mee"ng the standards and ra"ng us “Good” in all five core areas inspected. The report can be found at: www.cqc.org.uk .

What our pa!ents and carers say about us

Wellbeing service

Wellbeing Service evalua"ons are gathered via comment cards completed at "me of visit or via the feedback form on the hospice website.

Of those that commented on services (Monday and Thursday support Café, Tears to Laughter group, MND & HD support groups) 95% responses were posi"ve with 5% nega"ve or no comments. Nega"ve comments were linked to service changes and the withdrawal of free food.

Comment themes included:

Safe place to talk, value of the emo"onal support, access to informa"on about other community support available, support of staff and volunteers, enablement of peer support, and environment – peaceful, res=ul, wonderful grounds.

Direct quotes extracted include:-

“I came to visit with the lovely staff and forget all the worries in the world and forthcoming hospital visits.”

“A"er my husband died, I was very lonely. I was advised about the good work Treetops does. I came and they were right; this has helped me very much. Thank you.”

“A peaceful place to just be - no judgement suppor#ve and comfortable.”

“A"er bereavement I was very lonely. Coming here has helped me to become myself again. I now have people to talk to”.

Page 17

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>

Hospice at Home Service – Family or Carer Evalua!on

During the year, the Hospice at Home service supported 1,161 people and received 154 completed feedback ques!onnaires , represen"ng a 13.3% return rate . Feedback indicates a consistently compassionate, respec=ul and clinically confident service. Families reported very high levels of sensi"ve communica"on, feeling at ease with care, and support to remain in the preferred place of care. The clearest quan"ta"ve gap is informa"on pack reach: 71.8% of valid respondents recalled receiving one, although every valid respondent who rated the informa"on found it helpful. Capacity and access pressures, par"cularly overnight availability and call-back reliability, also appear in a small but important group of comments and should inform the 2026/27 improvement plan.

SURVEY RESPONSES PREFERRED PLACE OF CARE
COMMENTS RECEIVED
FAMILIES TOTALLY AT EASE
AND DEATH MET
153 126 95.0% 100.0%
Populated responses rows 82.4% of responses 132 of 139 valid responses 141 of 141 valid responses
REFERRAL SOURCES REFERRAL SOURCES
Source
Response Share of all Reponses
District nurse 64 41.8%
Pallia"ve care nurse 46 30.1%
District and pallia"ve nurse 17 11.1%
Hospital 14 9.2%
Other 7 4.6%
GP 1 0.7%
Not record/unclear 4 2.6%

Page 18

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[% !"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>

POSITIVE RESPONSE RATES
Measure
Posi!ve rates
Informa"on pack received 71.8%
Day care sufcient 92.5%
Night care sufcient 93.0%
Preferred place of care met 95.0%
Roaming care sufcient 97.1%
Referral "mely 98.6%
Knowledge always appropriate 99.3%
Family totally at ease 100.0%

The consistently low number of completed returns makes service evalua"on problema"c as it is hard to gain a true picture of the impact of the service on families and carers. The late stage at which referrals are received by the service and the subsequent number of care episodes provided for each individual may also be impac"ng on the number of service evalua"on forms being returned. As an organisa"on there is need to consider an alterna"ve way of obtaining feedback data.

Quotes from Hospice at Home - Carer evalua"ons 2025/26:

Page 19

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Counselling and Emo!onal Support Service

All clients who finish receiving support during the year from the Counselling and Emo"onal Support Services are asked to complete an evalua"on of their experience.

Adult Bereavement

137 evalua"on forms were sent out and 68 forms were returned (41%). This is down on last year where 172 from were sent out and 68 forms returned.

Quotes from evalua"ons, 2025/26 Bereaved Adults:

“I felt supported, understood and listened to.”

“I will admit it was difficult at first, but the people are so caring it became somewhere that felt safe.”

81#");A%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Parents/Carers of Bereaved Children

Demand for this service con"nues to be high and as a result we are opera"ng a wai"ng list in order to manage capacity. Therefore, children can be wai"ng longer to access the service.

Quotes from evalua"ons, 2025/26 Bereaved Children/Young People:

“It’s helped me speak to people more and when I first came, I didn’t like to talk and now because of F I can talk a bit more to people about how I feel.”

“Really friendly place that made me feel welcome as soon as I turned up for my first session. Every session I went to was really good.”

“Very friendly and kind.”

“It was a safe space for me to talk and helpful for learning some new ways of coping.”

“I’m so grateful for the help and the peace I found within the sessions, from inhabi#ng the techniques and posi#ve outlooks. I think Treetops is a great organisa#on.”

“It made me feel more confident and comfortable with the passing of my best friend.”

“Helped me be happier and feel less stress.”

“J was great and she was calm, honest, very suppor#ve and understanding. There was a lot to unpack within my sessions; there was more than just grief and she helped me do that. My life is so much be%er having had J there to help me. I will be forever grateful for the posi#ve impact she has made to my life and the #me and effort she has put in to support me.”

81#");9%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

Children/Young People

80 evalua"on forms were sent out of which 17 were returned (21%). We ask children/young people to rate how they were feeling at the beginning and the end of the support.

Quotes from evalua"ons, 2025/26 Bereaved Children/Young People

“Really friendly place that made me feel welcome as soon as I turned up for my first session. Every session I went to was really good.”

“Very friendly and kind.”

“It was a safe space for me to talk and helpful for learning some new ways of coping.”

“It made me feel more confident and comfortable with the passing of my best friend.”

“Helped me be happier and feel less stress.”

“J was great and she was calm, honest, very suppor#ve and understanding. There was a lot to unpack within my sessions; there was more than just grief and she helped me do that. My life is so much be%er having had J there to help me. I will be forever grateful for the posi#ve impact she has made to my life and the #me and effort she has put in to support me.”

Life-limi"ng Illness Counselling

14 evalua"on forms were sent out and 3 (21%) were returned.

The Life-Limi"ng Illness (LLI) work represents only a small part of our overall service delivery. The return rate could be a reflec"on of the health needs of these clients.

81#");;%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

f+Q&"%)^'Q,)"]1L+1&$Q%O);A;Bc;Z)I$^":I$,$&$#)GLL"%%)/L$"&%.%

“ ” C""L)1-L")&Q)VQX")-"&&"')U$&0),2)X'Q-L",%)1*()&0Q+#0&% _%

“ G&)0"LX"(),")^1V")&0")^1V&)&01&)&0")^+&+'")U1%)#Q$#)&Q)-")($^^"'"&)^'Q,)&0")Q")U")01()0QX"()^Q'_)G)1,),Q'")1VV"X&$#) Q^)^1V$#)V01#"%)1()("1L$#)U$&0)&0")+X'"($V&1-$L$&2)Q^),2)0+%-1(`%)$LL*"%% ”_

“ S ’ %)VQ+%"LL$#)%"%%$Q%)01]")#$]"),")&0")+("'%&1($#)Y1'Q+()U$(QU%)Q^)&QL"'1V"O)1b$"&2))X1$[)1()VQ^$("V") Y"U)&"V0$a+"%[)&Q),11#")&0")+V"'&1$&$"%)1()V01LL"#"%)Q^),2)&"',$1L)V1V"')1%)$&)X'Q#'"%%"%)G&),"1%)G)V1) VQ&$+")&Q)#Q)Q+&O)"#1#")U$&0)Q&0"'%)1()UQ'W)&Q)$,X'Q]"),2)a+1L$&2)Q^)L$^")G&)01%)0"LX"(),")&Q)-")1-L")&Q)%L""X)1&)$#0&) :)+%$#)%Q,")-'"1&0$#c'"L1b1&$Q)&"V0$a+"%)&01&)V1L,),")1()G)V1)+%")7L""X%V1X"%)&Q)0"LX_)G)+%")&0")-'"1&0$#) &"V0$a+"%)U0"),2)X1$)X"1W%):)1()$&)0"LX%)&Q)LQU"'c)'"(+V")&0")&$,")G`,)$*)($%&'"%% ”_

/Q,XL","*&1'2)50"'1X2)

B<)"]1L+1&$Q)^Q',%)U"'")%"&)Q+&)1();9)Y=Ag[)U"'")'"&+'"(_)%

• 9AAg)^"L&)&0")$^Q',1&$Q)'"V"$]"()1-Q+&)&0"$')&0"'1X2)U1%)0"LX^+L_%

f+Q&"%)^'Q,)"]1L+1&$Q%O);A;Bc;Z)/Q,XL","&1'2)50"'1X2.%

“ G&)'"1LL2)0"LX"(),")^Q')'"L1b1&$Q)1()0"LX$#),")%L""X_)&1LW$#)&0'Q+#0)&"V0$a+"%)&01&)UQ+L()0"LX)U1%)1)'"1L)-""^$& ”_

“ D)U1%)X'Q^"%%$Q1L)1&)1LL)&$,"%_)G)^Q+()&0"),1%%1#")'"1LL2)-""^$V$1L)1%)$&)"1-L"(),")&Q)+U$(O)",X&2),2),$()Q^)1LL)&0") &0$#%)#Q$#)1'Q+()$)$&_)D()#""'1LL2O)$&)"1-L"(),")&Q)'"L1b ”_

“ 70")U1%)-'$LL$1&O)%Q)W$()1()V1'$#)50")&'"1&,"&),1("),")^""L)%Q),+V0)-"&&"')X02%$V1LL2)1()",Q&$Q*1LL2 ”

“ J"LX"(),")&Q)VQ,XL"&"L2)'"L1b)U0$V0)$)&+')0"LX"(),")VQX")-"&&"')"1V0)(12 ”_

“ G)'"1LL2)%&'+##L")&Q)1LLQU),2%"L^)&Q)%LQU)(QU)1()^""L),2)",Q&$Q%_)D)U1%)X1'1,Q+&)$),")-"#$$#),2)eQ+'"2)Q^) 1LLQU$#)&0$%)1()&1W$#)&$,")Q+&)^Q'),2%"L^)G)1,)]"'2)#'1&"^+L)&Q)0"'O)G)01]")VQ&$+"()U$&0)%Q,")Q^)&0")&0"'1X$"%)&01&)U") ($( ”

“ F1("),")^""L)2Q+#)1#1$)1^&"')&0")&'"1&,"&)]"'2)VQ,^Q'&1-L")1()'"L1b"()1^&"' ”_

81#");<%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>

What our staff say about the organisa!on

There was a 63% response rate to this year’s Birdsong Employee Engagement Survey.

Treetops Highest Ten Engagement Factors:

Factors that resulted in high Employee Engagement are pride in Treetops reputa"on for excellent care, believing in the values of the charity and feeling comfortable being themselves at work.

Factors that require further development are communica"on par"cularly between different teams. Training and development opportuni"es for example, 49% of people agree they feel supported in developing their career (the benchmark is 57%). Work-related stress and pay and job security.

It has been a year of change at Treetops with the appointment of a new Chief Execu"ve. Some colleagues have been unse%led by change but overall the workforce is posi"ve and looking forward to a new era.

Complaints and Compliments

Complaints

During 2025/26, Treetops received five complaints rela"ng to Clinical Services and associated support func"ons. Each complaint or concern was reviewed, inves"gated and responded to in line with the hospice complaints process, with ac"ons taken where learning was iden"fied.

81#");=%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

-.N68M80837L'239'18=K/=023.8!,./3763<89>!

The underlying reasons for the complaints were:

Learning from these complaints included the need to strengthen communica"on between teams, ensure clear informa"on is provided to visitors and volunteers, and reinforce expecta"ons about respec=ul communica"on and professional conduct. Where issues involved external providers, concerns were appropriately escalated for inves"ga"on and follow-up.

Compliments

In addi"on to the posi"ve evalua"ons of our services, we con"nue to receive many emails, Facebook comments, individual cards and le%ers of thanks across the full range of services during the year. These compliments are shared with relevant service leads and teams so that good prac"ce can be recognised and celebrated.

We do not at present have a comprehensive way to capture and log all this feedback, and this posi"on has not changed. However, where individual staff members are named in compliments, "me is taken to personally thank them for their good prac"ce. Staff who are recognised as having gone above and beyond are also issued with Star Cards, helping to reinforce posi"ve prac"ce and acknowledge the impact of compassionate care.

Investment Policy and Performance

At the end of the financial year, the only investments are £10,000 invested in Treetops Funding Limited and £1,000 in Treetops Retail Limited.

81#");B%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

.',+,%'+/*0$('$1

a) Going Concern

A$er making appropriate enquiries, the Trustees have a reasonable expecta"on that the company has adequate resources to con"nue in opera"onal existence for the foreseeable future. For this reason, they con"nue to adopt the going concern basis in preparing the financial statements..

b) Results for the year

The Charity’s gross income increased from £5,162,288 to £5,706,548, an increase of £544,260. Gross costs increased from £5,453,525 to £6,068,296, an increase of 11.27%, which was within the targets approved by the budget.

The charity had funds carried forward at 31 March 2026 of £4,810,030 (2025: £5,171,778) of which £113,745 (2025: £155,468) are restricted funds, £2,020,600 (2025: £2,401,924) are unrestricted funds and £2,675,685 (2025: £2,614,386) are designated funds.

Treetops Funding Limited and Treetops Retail Limited

In 2003, Treetops Retail Limited was created for the Retail shops and catering opera"on. From 1 April 2018 onwards, the Retail shops were transferred over to Treetops Hospice Trust to ensure Gi$ Aid claims were correctly dealt with and did not leave the subsidiary company insolvent. Treetops Retail Limited now only contains the catering opera"on and is part of the VAT registered group with Treetops Hospice Trust.

The Charity’s wholly owned trading subsidiaries carry out non-charitable trading ac"vi"es for the Charity.

Funding Company – Treetops Hospice Lo&ery

The Funding Company’s turnover fell from £692,664 to £684,966 (1.11%), profit decreased from £417,591 to £378,166 (9.44%). Membership levels were over 12,400 ac"ve members by the year end. As these numbers have stagnated and fallen slightly in recent years due to in part to the recent economic crisis, a new strategy is in place to encourage these numbers to grow again, which will see the price per "cket increase for the first "me in the 30 years since the Lo%ery started opera"on.

Retail Company

Treetops Retail Limited is currently a dormant company. These accounts cover the financial posi"on of the catering outlets only which are currently not trading due to uncertainty following the Covid pandemic. It is not currently known if or when trading will resume.

81#");Z%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

.',+,%'+/0$('$12%3,&',4$-5!

Fundraising

Legacy income has experienced an increase rising from £238,793 to £410,693. The legacy strategy implemented a few years ago is s"ll in place and showing signs of keeping legacy dona"ons at a strong level, especially given early performance in the new financial year.

c) Principal risks and uncertain!es

The Board has agreed a risk management structure for the organisa"on and has iden"fied the major risks to which the organisa"on is exposed, which are reviewed at a minimum every three to six months and appropriate mi"ga"ng ac"on is taken accordingly.

The most recent review showed that the highest risks as:

d) Reserves policy

The Board of Trustees regularly review the level of reserves to ensure that fund levels are appropriate for the current ac"vi"es and long term aims, should they need to be called upon. The Reserves Policy forms part of our Finance Policies and can be provided upon request.

The review takes into account the changes arising from the updated Organisa"onal Strategy, and reflects any addi"onal strains from the current economic climate and infla"onary impacts. The chosen approach is to establish the financial obliga"on on the organisa"on in three different scenarios – ceasing to trade, six months trading costs (excluding Income Genera"on) and providing for any forecast deficits over the next four financial years. Once these figures are established, the Board will then use these amounts to determine a suitable Reserves range that ensures the financial stability of the organisa"on, whilst ensuring it can deliver on its charitable aims and purposes.

At the last review, this methodology produced a Free Reserves range of £1.35m - £1.85m. The Trustees are sa"sfied with the reserves level and feel it is at a sa"sfactory level for the organisa"on to discharge its obliga"ons and long-term plans.

&7=<.7<=8O!;/M8=323.8'239'0232;80837!

64 9/(#&'&,&'/(!

Treetops Hospice is a registered charity and company limited by guarantee without share capital and was set up on 20 March 1984 under the name Drayco% Hospice Associa"on. The name of the company was changed to Treetops Hospice Trust on 21 June 1993. The charity’s governing document is its Memorandum and Ar"cles of Associa"on (last amended on 24 November 2008), which restrict the charity’s opera"ons to all such lawful acts as are incidental or necessary to the a%ainment of its objec"ves.

81#");>%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

&7=<.7<=8O!;/M8=323.8'239'0232;80837!9./3763<89>

b) Method of appointment or elec!on of Trustees

The management of the company is the responsibility of the Trustees who are elected and co-opted under the terms of the Ar"cles of Associa"on.

c) Policies adopted for the induc!on and training of Trustees

The Board agreed a wri%en structure for the induc"on of new Trustees, and a code of conduct for Trustees and the Chief Execu"ve. Trustee induc"on is managed by the Chief Execu"ve and the Company Secretary and includes wri%en informa"on on the following topics:

All new Trustees will spend "me with the Chair of the Board and the Chief Execu"ve at an early stage. The charity subscribes to Governance a journal for Trustees. All Trustees receive individual copies and a copy is held in the general office and Trustees are given informa"on on relevant training courses.

d) Pay policy for senior staff

It is the policy of the Board of Trustees to remunerate the Senior Leadership Team (SLT) in line with market forces and pay an acceptable salary that in general is in line with the charity sector and specifically hospices, which will a%ract and keep quality staff.

The SLT are only awarded pay increases in line with the cost of living annual award given to all staff and will not receive and other financial recogni"on. The cost of living increase is discussed by the Board of Trustees annually and is awarded in line with the charity’s performance, affordability and external indicators, such as the cost of living index.

e) Organisa!onal structure and decision making

The responsibility to ensure appropriate management of the charity is vested in the Board of Trustees, a third of which are elected annually by the members of the Company. To assist the Board in discharging its responsibili"es, it receives regular reports on some aspects of its principle func"ons from the Finance and Income Genera"on, People and Culture and the Clinical sub commi%ees. These commi%ees consist of members of the Board of Trustees and senior members of staff. The Finance and Income Genera"on sub commi%ee meet to review the financial ac"vity every quarter, as do the Clinical sub commi%ee who monitor clinical services. The People and Workforce group currently met on a more regular basis whilst the commi%ee establishes itself. The Board also meets quarterly with addi"onal mee"ngs as required.

The Chief Execu"ve, who leads the SLT, is responsible to the Board of Trustees for the day to day management of the charity and the execu"on of the policies and strategies defined by the Board.

81#");?%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

,-'./01234'5606789':4';<2=23788>!

"#$$"%&''(%'&)*$'"#+'"!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

&7=<.7<=8O';/M8=323.8'239'0232;80837',./3763<89>

f) Risk management

The Board has agreed a risk management structure for the organisa"on and has iden"fied the major risks to which the organisa"on is exposed, these are reviewed periodically depending on the nature of the risk and appropriate mi"ga"ng ac"ons to be taken. The Health and Safety commi%ee con"nue to ensure that all relevant issues are considered and addressed at departmental level and the Health and Safety Responsible Person prepares quarterly Health and Safety reports for the Board.

%523L'K/='B<7<=8'%8=6/9L!

Our priori"es for 2026/27 are shaped by Treetops’ new three year strategy, Cra"ing the Future of Hospice Care , which has now moved from development into implementa"on and delivery. The strategy sets out a clear ambi"on for Treetops to be recognised as central and southern Derbyshire’s modern community specialist hospice: delivering expert clinical care in the community, strengthening our role as a centre of excellence for trauma informed emo"onal and psychological support, and developing our posi"on as a trusted provider of pallia"ve and end of life care educa"on. Opera"onal development and delivery will be measured against the ambi"ons and priori"es set out in the strategy so that progress, resource alloca"on and impact can be monitored consistently as we move forward.

The strategy recognises the changing context in which hospice care is delivered and aligns with the na"onal direc"on of travel for pallia"ve and end of life care. Demand and complexity are increasing, tradi"onal hospice bed capacity is reducing na"onally, and more people wish to receive care and die in the place they call home. At the same "me, na"onal policy and NHS priori"es are increasingly focused on care closer to home, earlier iden"fica"on of need, equitable access, personalised care, reduced avoidable hospital admission and stronger community based support. Treetops will therefore con"nue to align its future developments with the emerging Modern Service Framework for Pallia"ve and End of Life Care, consolida"ng its clinical offer, strengthening specialist skills, improving access and responsiveness, and demonstra"ng impact through outcomes as well as ac"vity.

In 2026/27, we will focus on the following priori"es, each of which reflects the opportuni"es and development areas iden"fied within the strategy and is intended to support alignment with emerging na"onal expecta"ons.

To support delivery, each priority will be translated into measurable opera"onal objec"ves, with clear ownership, milestones and repor"ng routes through the senior leadership team, Clinical Sub-commi%ee and Board of Trustees. This will ensure that progress against the strategy is visible, that risks and dependencies are iden"fied early, and that service development remains aligned with quality, workforce capacity and financial sustainability.

Establishing a clear community specialist hospice model

We will develop and embed a clear, evidence based clinical model that describes what Treetops provides as a progressive community hospice. This will bring together specialist home based pallia"ve and end of life care, dynamic assessment of need, future care planning, emo"onal wellbeing and trauma informed therapeu"c support. The model will clarify target popula"ons, referral pathways, access criteria, service standards and measurable outcomes so that pa"ents, families, professionals, commissioners and the public understand what Treetops offers and where it can make the greatest impact. This work will be informed by the Modern Service Framework’s emphasis on earlier iden"fica"on, equitable access, integrated community models and outcomes that reflect what ma%ers to people and those important to them.

81#");@%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

%523L'K/='K<7<=8'18=6/9L',./3763<89>!

Improving access, triage and care coordina!on

We are working to strengthen routes into our clinical services so that there is a clearer, more responsive and more consistent experience for people seeking support. This will include developing a single point of access approach delivered through a coordina"on hub. This will improve first contact conversa"ons, strengthening triage and priori"sa"on, and ensuring that people are either connected to the right Treetops service or signposted effec"vely to other appropriate support. The aim is to create a “no wrong door” approach while ensuring specialist clinical capacity is focused where need is greatest.

Care coordina"on will also be strengthened across Hospice at Home, the Roaming Nurse Service, therapeu"c services and community-based support. This will help improve handover, reduce duplica"on, support "mely decision making and ensure pa"ents and families receive coordinated care during periods of deteriora"on, crisis or increasing complexity.

Developing specialist home based pallia!ve and end of life care

A central priority for 2026/27 is to further develop specialist care delivered at home and in the community. This includes strengthening Hospice at Home and the Roaming Nurse Service, suppor"ng people with complex symptom management, enabling rapid response during periods of crisis, and helping more people remain in their preferred place of care wherever possible. We will con"nue to use our data to evidence the value of home based interven"on, including its contribu"on to pa"ent choice, carer reassurance, admission avoidance and wider system benefit.

Preparing for extended access and future 24/7 provision

The strategy sets a longer-term ambi"on for Treetops to move towards a 24-hour, seven day community specialist hospice model, subject to workforce and funding capacity. During 2026/27, we will lay the founda"ons for this by reviewing demand, workforce requirements, skill mix, rotas, escala"on pathways and affordability. We will explore phased extension of access where there is clear evidence of need and where provision can be delivered safely and sustainably within our available resources.

81#")<A%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

%523L'K/='K<7<=8'18=6/9L',./3763<89>!

Embedding trauma-informed emo!onal and psychological support

Therapeu"c Services will remain central to the Treetops offer. We will con"nue to strengthen our trauma informed counselling and emo"onal support for adults, children, young people and families affected by life-limi"ng illness, death and bereavement. This includes sustaining our centre of excellence approach, developing pathways for those with the greatest complexity, suppor"ng student placement models and using evalua"on and outcomes data to demonstrate impact. During 2026/27, we will also work in collabora"on with University Hospitals of Derby and Burton to establish a counsellor posi"on on the Nigh"ngale Macmillan Unit, providing vital counselling and emo"onal support to pa"ents and families on the unit. In addi"on, we will further develop the Complementary Therapy service to support student placements and prac"ce placement "me for newly qualified therapists. This will help grow the service, strengthen future capacity and posi"on Treetops as a trailblazer in developing supported prac"ce opportuni"es within hospice based Complementary Therapy.

Posi!oning Treetops as a system educa!on provider

Educa"on is a core strategic opportunity. We will con"nue to develop Treetops’ role as a trusted educa"on partner within the Integrated Care System, providing high quality learning for our own workforce and for partners across care homes, primary care, community services, domiciliary care and wider health and social care se&ngs. Priori"es include advanced communica"on skills, future care planning, recognising deteriora"on, symptom management, verifica"on and trauma informed prac"ce. This will support system wide improvement while strengthening Treetops’ profile, influence and commissioning credibility.

Building a skilled, flexible and supported workforce

Delivery of the strategy depends on the skills, resilience and commitment of our staff and volunteers. During 2026/27, we will align workforce planning with our future clinical model, strengthen specialist pallia"ve care capability, ensure staff receive regular support and appraisal, and con"nue to develop training, supervision and reflec"ve prac"ce. We will also support the implementa"on of the revised clinical structure and use staff feedback to inform improvements in communica"on, wellbeing, development and culture.

Reviewing and developing volunteering opportuni!es

Volunteers remain at the heart of Treetops and con"nue to make a significant contribu"on across clinical services. In 2026/27, we will review how volunteering is managed and supported so that opportuni"es are clearly aligned to the future strategy, make best use of volunteer skills and con"nue to offer meaningful ways for volunteers to contribute to the clinical services of our hospice.

Strengthening partnerships, commissioning and system influence

We will con"nue to work closely with Derby and Derbyshire Integrated Care Board and the newly formed ICB cluster, acute trust, primary care, community providers, care homes and voluntary sector partners. Our aim is to co-design integrated pathways for home based end of life care, crisis response, educa"on and emo"onal support. This partnership work will be aligned with na"onal expecta"ons for strategic commissioning of hospice and pallia"ve care services, including integrated needs assessment, sustainable contrac"ng, reducing unwarranted varia"on and demonstra"ng the contribu"on Treetops can make to admission avoidance, discharge facilita"on, pa"ent choice, quality of care and system resilience.

81#")<9%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

%523L'K/='K<7<=8'18=6/9L',./3763<89>!

)01=/M63;'8W<674'/K'2..8LL'239'./00<3674'=82.N!

R")'"VQ#$%")^'Q,)Q+')QU)(1&1)&01&)&0"'")'",1$%),Q'")&Q)(Q)&Q)$,X'Q]")"a+$&2)Q^)1VV"%%)1V'Q%%)&0")VQ,,+$&$"%)U")%"']"O) X1'&$V+L1'L2)$)1'"1%)Q^)("X'$]1&$Q)1()1,Q#)VQ,,+$&$"%)&01&)01]")0$%&Q'$V1LL2)-"")+("''"X'"%"&"()$)0Q%X$V")%"']$V"%_) E+'$#) ;A;Zc;>O) U") U$LL) %&'"#&0") VQ,,+$&2) "#1#","&O) ("]"LQX) '"L1&$Q%0$X%) U$&0) LQV1L) "&UQ'W%O) +%") (1&1) &Q) +("'%&1() #1X%) $) '"1V0O) 1() "%+'") %"']$V") ("]"LQX,"&) $%) $^Q',"() -2) &0") "bX"'$"V"%) 1() X'"^"'"V"%) Q^) X1&$"&%O) ^1,$L$"%O)V1'"'%)1()VQ,,+$&$"%_%

D)W"2)X'$Q'$&2)^Q')&0")VQ,$#)2"1')U$LL)-")&Q)("L$]"')&0")0Q,"L"%%"%%)X'Qe"V&)$)E"'-2)1()+%")&0$%)&Q)"01V")1U1'""%%O) 1VV"%%) 1() "#1#","&) U$&0) X"QXL") U0Q) ,12) Q&) &'1($&$Q1LL2) 1VV"%%) 0Q%X$V") %+XXQ'&) 50") X'Qe"V&) U$LL) $,X'Q]") "1'L2) $("&$^$V1&$Q)Q^)X"QXL")"bX"'$"V$#)0Q,"L"%%"%%)U0Q)1'")L$]$#)U$&0)%"'$Q+%)$LL:0"1L&0)1()%&'"#&0")"a+$&1-L")1VV"%%)&Q) X1LL$1&$]")1()"*()Q^)L$^")V1'"%

RQ'W$#)$)X1'&"'%0$X)U$&0)E"'-2)/$&2)L"1()N8%O)LQV1L)0Q,"L"%%"%%)%"']$V"%)1()+%$#)&0")4Q)M1''$"'%)J"'"),Q("LO)5'""&QX%) U$LL)$:'"1V0)&Q)X"QXL")^1V$#)^$1V$1L)01'(%0$XO)$("&$^2)+,"&)""(%)"1'L$"')1()#1&0"')(1&1)&Q)"]1L+1&")&0")X'Qe"V&’%)$,X1V&) Q)'",Q]$#)-1''$"'%)&Q)V1'")50")X'Qe"V&)U$LL)X$LQ&)"U)VQLL1-Q'1&$]")1XX'Q1V0"%O)&'1$)^'Q&L$")X'Q^"%%$Q1L%)1()0Q%X$V") %&1^^O)1()VQ:V'"1&")X1&$"&:V"&'"()V1'")VQ]"'%1&$Q%)&01&)0"LX)X'"]"&)V'$%$%)X'"%"&1&$Q%)1*()&'1+,1:'"L1&"()("1&0%%

)3K/=0276/3'/3'B<39=26L63;'%=2.76.8L!

DLL)%&1^^)1()]QL+&""'%)'"1()&0")5'""&QX%)JQ%X$V")5'+%&)XQL$V$"%)Q)^+('1$%$#)1%)X1'&)Q^)&0"$')$(+V&$Q_))DLL)Q+&%$(")1#"V$"%) 1'")'"#$%&"'"()U$&0)1XX'QX'$1&")'"#+L1&Q'2)-Q($"%)1()%$#)1#'"","&%)U$&0)5'""&QX%)JQ%X$V")5'+%&)'"#1'($#)XQL$V$"%)Q) ^+('1$%$#)1()N""'1L)E1&1)8'Q&"V&$Q)!"#+L1&$Q)VQ,XL$1V"_%

7&1^^)1()]QL+&""'%)1&&"()&'1$$#)%"%%$Q%)Q)%X"V$^$V)1%X"V&%)Q^)^+('1$%$#)"#)VQLL"V&$Q%O)1()1'")#$]")&0")C+('1$%$#) !"#+L1&Q'%)/Q(")Q^)C+('1$%$#)8'1V&$V")^Q')&01&)X1'&$V+L1')1V&$]$&2_%

M'"1V0)Q^)12)Q^)&0")XQL$V$"%)$%)("1L&)U$&0)-2)&0")J"1()Q^)/Q,,+$&2)!"L1&$Q%0$X%O)J"1()Q^)!"&1$L)Q')HQL+&""'%)7"']$V"%)$) L$")U$&0)&0")5'""&QX%)JQ%X$V")5'+%&)]QL+&""')X'QV"(+'"%_)D2)-'"1V0)-2)1)X1$()^+('1$%"')UQ+L()-")01(L"()&0'Q+#0)&0") 5'""&QX%)JQ%X$V")E$%V$XL$1'2)8QL$V2)1()8'QV"(+'")5'""&QX%)JQ%X$V")1L%Q)01%)1)VL"1')N$^&)8QL$V2)Q)1VV"X&$#)Q')1-+%$#) XQ%$&$Q)^Q')'"V"$]$#),Q"2c#$^&%%

G^)5'""&QX%)JQ%X$V")5'+%&)$%)Q&$^$"()Q^)&0$'()X1'&2)^+('1$%$#)"]"&%O)12)X"'%Q)^'Q,)1)#'Q+X)Q')12)$($]$(+1L)0QL($#)&01&) "]"&O)$^Q',%)+%)&Q)"%+'")&01&)U")1'")1U1'")Q^)&0")"]"&’%)("&1$L%O)&0"2)1'")VQ,XL$1&O)1()&01&)&0"),Q"2)$%)'"V"$]"()1^&"') &0")"]"&_)50$%)$%),Q$&Q'"()-2)&0")/Q,,+$&2)!"L1&$Q%0$X%)&"1,_%

5'""&QX%)JQ%X$V")5'+%&’%)$VQ,")#""'1&$Q)("X1'&,"&)Q'#1$%"%)^+('1$%$#)"]"&%)1()VQ:Q'($1&"%)&0")1V&$]$&$"%)Q^)Q+') %+XXQ'&"'%)-Q&0)$)&0")JQ%X$V")1()$)&0")U$("')VQ,,+$&2)Q)-"01L^)Q^)&0")V01'$&2_)50")("X1'&,"&)01%)%$#"()+X)&Q)&0") C+('1$%$#)!"#+L1&Q'’%)/Q(")Q^)C+('1$%$#)8'1V&$V"O)1()&0")Q'#1$%1&$Q)1%)1)U0QL")1(0"'"%)&Q)&0")N""'1L)E1&1)8'Q&"V&$Q) !"#+L1&$Q*%_%

DLL)($'"V&),1'W"&$#)$%)+("'&1W")-2)&0")GVQ,")N""'1&$Q)1()F1'W"&$#)("X1'&,"&%)&Q)"%+'")&01&)$&)$%)Q&)+'"1%Q1-L2) $&'+%$]")Q')X"'%$%&"&_)DLL),1'W"&$#),1&"'$1L)VQ&1$%)VL"1')$%&'+V&$Q%)Q)0QU)1)X"'%Q)V1)-")'",Q]"()^'Q,),1$L$#)L$%&%O) 1%)(Q)1LL)L"&&"'%)Q^)&01*W%_%

5'""&QX%) JQ%X$V") IQ&&"'2) (Q"%) +%") &0$'() X1'&2) V1]1%$#) VQ,X1$"%) &Q) '"V'+$&) ,",-"'%) Q^) &0") IQ&&"'2_) E1&1) 8'Q&"V&$Q) D#'"","&%)1'")$)XL1V")U$&0)&0Q%")VQ,X1$"%O)U0$V0)VQ^$',%)&01&)&0"2)1(0"'")&Q)&0")C+('1$%$#)!"#+L1&Q'’%)/Q(")Q^) C+('1$%$#)8'1V&$V")1()&0")N""'1L)E1&1)8'Q&"V&$Q)!"#+L1&$Q%_%

81#")<;%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&' (%'&)*$ "#+'"

,-'./01234'5606789':4';<2=23788>

5!K75667`)JX0,J5%Y.ZK+Y[%I5J)5X[Y.%JX0,J5 Y/345G4K6E[

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102

&72780837'/K'!=<L788L?'=8L1/3L6:656768L

567 53849774 YU0Q 1'" 1L%Q &0" ($'"V&Q'% <B &0" /Q,X12 B<3 &0" X+'XQ%"% =;G 1'" '"%XQ%$-L" ^Q' X'"X1'$# &0" 53849774H '"XQ'& $VL+($# &0" 7&'1&"#$V '"XQ'& 1( &0" ^$1V$1L %&1&","&% $ 1VVQ'(1V" U$&0 1XXL$V1-L" L1U 1( K$&"()T$#(Q,)DVVQ+&$#)7&1(1'(%)YK$&"()T$#(Q,)N""'1LL2)DVV"X&"()DVVQ+&$#)8'1V&$V"[_

/Q,X12 L1U '"a+$'"% &0" 53849774 &Q X'"X1'" ^$1V$1L %&1&","&% ^Q' "1V0 ^$1V$1L 2"1' K("' VQ,X12 L1UO &0" 53849774%,+%&)Q&)1XX'Q]")&0")^$1V$1L)%&1&","&%)+L"%%)&0"2)1'")%1&$%^$"()&01&)&0"2)#$]")1)&'+")1()^1$')]$"U)Q^)&0")%&1&" <B =BB=@34 <B &0" N'Q+X 1( &0" /Q,X12 1( <B &0"$' $VQ,$# 374<83A74 1( 1XXL$V1&$Q <B '"%Q+'V"%O $VL+($# &0"$' $VQ,")1()"bX"($&+'"O)^Q')&01&)X"'$Q()G)X'"X1'$#)&0"%")^$1V$1L)%&1&","*&%O)&0" 53849774%1'")'"a+$'"()&Q.

  • %"L"V&)%+$&1-L")1VVQ+&$#)XQL$V$"%)1()&0")1XXL2)&0",)VQ%$%&"&L2d

  • Q-%"']")&0"),"&0Q(%)1()X'$V$XL"%)Q^)&0")/01'$&$"%)73!8 :-JI "!MGa

  • ,1W")e+(#,"&% 1()1VVQ+&$#)"%&$,1&"%)&01&)1'")'"1%Q1-L")1()X'+("*&d

  • %&1&" U0"&0"' 1XXL$V1-L" KL DVVQ+&$# 7&1(1'(% :-JI "!MG 01]" -"" ^QLLQU"(O %+-e"V& &Q 12 ,1&"'$1L ("X1'&+'"%)($%VLQ%"()1()"bXL1$"()$)&0")^$1V$1L)%&1&","*&%d

  • X'"X1'" &0" ^$1V$1L %&1&","&% Q &0" #Q$# VQV"' P=4@4 8E>744 $& @4 $1XX'QX'$1&" &Q D3748C7 &01& &0" N'Q+X U$LL)VQ&$+")$)-+%$"%%_

567 53849774 1'" '"%XQ%$-L" ^Q' ,1$&1$$# 1("a+1&" 1VVQ+&$# '"VQ'(%)&01& ($%VLQ%")U$&0)'"1%Q1-L")1VV+'1V2)1&)12 &$,") &0")^$1V$1L)XQ%$&$Q)Q^ &0" N'Q+X)1()&0" /Q,X12 1( "1-L" &0", &Q "%+'" &01& &0" ^$1V$1L %&1&","&% VQ,XL2 U$&0 &0" /Q,X1$"% DV& M!!bR 50"2 1'")1L%Q '"%XQ%$-L" ^Q' %1^"#+1'($# &0" =44794 <B &0" N'Q+X =E?%967 /Q,X12 =E?%67EA7% B<3%9=U@EV%37=47%497D4%B<3%967 X'"]"&$Q)1()("&"V&$Q)Q^)^'1+()1()Q&0"')$''"#+L1'$&$"%_

A6L.5/L<=8'/K'63K/=0276/3'7/'2<967/=

61V0)Q^)&0")X"'%Q%)U0Q)1'" 53849774%1&)&0")&$,")U0")&0$% 5'+%&""%`)'"XQ'&)$%)1XX'Q]"()01%)VQ*^$',"()&01&.

  • 4< ^1' =4 &01& 5384977 $% 1U1'"O &0"'" @4 Q '"L"]1& 1+($& $^Q',1&$Q <B U0$V0 &0" V01'$&1-L" #'Q+X`% 1+($&Q' $% +1U1'"O 1(

  • &01& 5384977 01%)&1W")1LL)&0")%&"X%)&01&)Q+#0&)&Q)01]")-"")&1W")1%)1 5384977%$)Q'("')&Q)-")1U1'")Q^)12)'"L"]1& 1+($&)$^Q',1&$Q)1()&Q)"%&1-L$%0)&01&)&0" V01'$&1-L" #'Q+X`% 1+($&Q')$% 1U1'")Q^)&01&)$^Q',1&$Q*_

G 1XX'Q]$# &0" 53849774H '"XQ'&O ;7 1L%Q 1XX'Q]" &0" 7&'1&"#$V '"XQ'& $VL+("( &0"'"$O $ Q+' V1X1V$&2 =4 VQ,X12 ($'"V&Q'%_

DXX'Q]"()-2)Q'("')Q^)&0"),",-"'%)Q^)&0")-Q1'()Q^ 53849774%1()%$#"()Q*)&0"$')-"01L^)-2.

………………………………

F')/)NL2**

E1&". 06/10/2026

81#")<<

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

Y+X0X+X*5 )K+Y5,JHI JX0,J5 53)5_X /X/^XJI ,- 5JXX5,0I _,I0Y.X 5JKI5

Opinion

We have audited the financial statements of Treetops Hospice Trust (‘the charitable group’) for the year ended 31 March 2026 which comprise the Consolidated Statement of Financial Ac"vi"es, the Consolidated Balance Sheet, the Charity Balance Sheet, the Consolidated Statement of Cashflows and notes to the financial statement, including significant accoun"ng policies. The financial repor"ng framework that has been applied in their prepara"on is applicable law and United Kingdom Accoun"ng Standards, including FRS 102 The Financial Repor"ng Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accoun"ng Prac"ce).

In our opinion the financial statements:

  • give a true and fair view of the state of the group’s and parent charitable company’s affairs as at 31 March 2026, and of the group’s incoming resources and applica"on of resources, including its income and expenditure, for the year then ended;

  • have been properly prepared in accordance with United Kingdom Generally Accepted Accoun"ng Prac"ce; and

  • • have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with Interna"onal Standards on Audi"ng (UK) (ISAs (UK)) and applicable law. Our responsibili"es under those standards are further described in the Auditor's responsibili"es for the audit of the financial statements sec"on of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard and we have fulfilled our other ethical responsibili"es in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

*/3.5<L6/3L'=852763;'7/';/63;'./3.8=3

G 1+($&$# &0" ^$1V$1L %&1&","&%O ;7 01]" VQVL+("( &01& &0" 93849774H 847 <B &0" #Q$# VQV"' P=4@4 <B 1VVQ+&$# $ &0")X'"X1'1&$Q)Q^)&0")^$1V$1L)%&1&","&%)$%)1XX'QX'$1&"_

M1%"( Q &0" UQ'W ;7 01]" X"'^Q',"(O ;7 01]" Q& $("&$^$"( 12 ,1&"'$1L +V"'&1$&$"% '"L1&$# &Q 7N7E94 Q' VQ($&$Q% &01&O $($]$(+1LL2 Q' VQLL"V&$]"L2O ,12 V1%& %$#$^$V1& (Q+-& Q &0" #'Q+X 1( X1'"& V01'$&1-L" VQ,X12i% 1-$L$&2 &Q VQ&$+" =4 1 #Q$# VQV"' ^Q' 1 X"'$Q( N7 ,Q&0% B3<C U0" &0" ^$1V$1L %&1&","&% 1'" 1+&0Q'$%"( ^Q' @4487R

3+' '"%XQ%$-$L$&$"% 1( &0" '"%XQ%$-$L$&$"% <B &0" &'+%&""% U$&0 '"%X"V& &Q #Q$# VQV"' 1'" ("%V'$-"( $ &0" '"L"]1& %"V&$Q*%)Q^)&0$%)'"XQ'&_

$7N8='63K/=0276/3

The other informa"on comprises the informa"on included in the annual report other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other informa"on contained within the financial statements. Our opinion on the financial statements does not cover the other informa"on and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other informa"on and, in doing so, consider whether the other informa"on is materially inconsistent with the financial statements, or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we iden"fy such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other informa"on. If, based on the work we have performed, we conclude that there is a material misstatement of this other informa"on, we are required to report that fact.

81#")<=

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

Y+X0X+X5))K+Y5,JHI)JX0,J5)53)5_X)/X/^XJI),-% 5JXX5,0I)_,I0Y.X)5JKI5):.,5Y*KX+G%

R")01]")Q&0$#)&Q)'"XQ'&)$*)&0$%)'"#1'(_%

$1636/3L'/3'/7N8='02778=L'1=8L.=6:89':4'7N8'*/012368L'-.7!HIIJ!

G)Q+')QX$$QO)-1%"()Q)&0")UQ'W)+("'&1W")$*)&0")VQ+'%")Q^)&0")1+($&.%

  • the informa"on given in the trustees' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the trustees' report has been prepared in accordance with applicable legal requirements.

D2778=L'/3'PN6.N'P8!2=8'=8W<6=89'7/'=81/=7!:4'8Q.8176/3!

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not iden"fied material misstatements in the trustees' report

c7%01]"%Q&0$#%&Q%'"XQ'&%$%'"%X"V&%<B%&0"%^QLLQU$#%,1&&"'%%$%'"L1&$Q%&Q%U0$V0%&0"%/Q,X1$"%%DV&%M!!b%'"a+$'"%%84%&Q% '"XQ'&)&Q)2Q+)$^O)$)Q+'%QX$$Q.%

  • adequate accoun"ng records have not been kept by the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us; or

  • the parent charitable company financial statements are not in agreement with the accoun"ng records and returns; or

  • certain disclosures of trustees' remunera"on specified by law are not made; or

  • we have not received all the informa"on and explana"ons we require for our audit.

"8L1/3L6:656768L'/K'7=<L788L!

As explained more fully in the trustees' responsibili"es statement set out on page 33, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the prepara"on of the financial statements and for being sa"sfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the prepara"on of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the group and parent charitable company’s ability to con"nue as a going concern, disclosing, as applicable, ma%ers related to going concern and using the going concern basis of accoun"ng unless the trustees either intend to liquidate the charitable company or to cease opera"ons, or have no realis"c alterna"ve but to do so.

-<967/='=8L1/3L6:656768L'K/='7N8'2<967'/K'7N8'K6323.625'L72780837L!

Our objec"ves are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

81#")<B%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

Y+X0X+X5))K+Y5,JHI)JX0,J5)53)5_X)/X/^XJI),-% 5JXX5,0I)_,I0Y.X)5JKI5):.,5Y*KX+G%

Irregulari"es, including fraud, are instances of non-compliance with laws and regula"ons. We design procedures in line with our responsibili"es, outlined above, to detect material misstatements in respect of irregulari"es, including fraud. The extent to which our procedures are capable of detec"ng irregulari"es, including fraud is detailed below.

Based on our understanding of the group and charitable company and the industry in which it operates, we iden"fied that the principal risks of non-compliance with laws and regula"ons related to the acts by the charitable company, which were contrary to applicable laws and regula"ons including fraud, and we considered the extent to which non-compliance might have a material effect on the financial statements. We also considered those laws and regula"ons that have a direct impact on the prepara"on of the financial statements such as the Companies Act 2006. We evaluated management’s incen"ves and opportuni"es for fraudulent manipula"on of the financial statements (including the risk of override of controls) and determined that the principal risks were related to stock valua"on and legacy income.

Audit procedures performed by the engagement team included:

  • reviewing the systems, controls and procedures of the charity relevant to the prepara"on of the financial statements to ensure these were in place throughout the year;

  • evalua"ng management’s controls designed to prevent and detect irregulari"es;

  • review of the financial statement disclosures to underlying suppor"ng documenta"on;

  • enquiries of management in so far as they related to the financial statements;

  • tes"ng of journals in par"cular journal entries posted by unusual users, pos"ngs with unusual descrip"ons, pos"ngs with unusual "mes and dates and pos"ngs with unusual and material amounts;

  • evalua"ng whether there was evidence of bias by the trustees that represented a risk of material misstatement due to fraud;

  • challenging assump"ons and judgements made by management in their cri"cal accoun"ng es"mates;

  • reviewing legacies to ensure income is being recognised in line with the relevant performance obliga"ons and correctly classified in line with the applicable financial repor"ng standards; and

  • reviewing and tes"ng stock values pre and post year end to ensure stock is correctly stated.

Because of the inherent limita"ons of an audit, there is a risk that we will not detect all irregulari"es, including those leading to a material misstatement in the financial statements or non-compliance with regula"on. This risk increases the more that compliance with a law or regula"on is removed from the events and transac"ons reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregulari"es occurring due to fraud rather than error, as fraud involves inten"onal concealment, forgery, collusion, omission or misrepresenta"on.

A further descrip"on of our responsibili"es for the audit of the financial statements is located on the Financial Repor"ng Council’s website at: h%p://www.frc.org.uk/auditorsresponsibili"es. This descrip"on forms part of our auditor’s report.

81#")<Z%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&' (%'&)*$ "#+'"

,-'./01234'5606789':4';<2=23788>

Y+X0X+X5 )K+Y5,JHI JX0,J5 53)5_X /X/^XJI ,- 5JXX5,0I _,I0Y.X 5JKI5 :.,5Y*KX+G

+L8'/K'/<='=81/=7

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those ma%ers we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permi%ed by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

……………………………….

E1]$( DLL+, Y7"*$Q')%&1&+&Q'2)1+($&Q'[

^Q')1()Q)-"01L^)Q^

+(E'(2.S8='E/<3; 14 Park Row *<99@EV6=C 4N9)ZN!

E1&". 08/10/2026

81#")<>

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

/3473IGED56E)75D56F645),-)CG4D4/GDI)D/5GHG5G67)YG4/3!83!D5G4N)G4/3F6))*+)6j864EG5K!6% D//3K45[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

+3=8L7=6.789 "8L7=6.789 !/725 5Q&1L
K<39L K<39L K<39L ^+*(%
:;:< :;:< :;:< M!M&
@/78 X X X k
)3./08K=/0Y
EQ1&$Q%1*(L"#1V$"% = 1,389,923 67,748 1,457,671 1,274,413
/01'$&1-L"1V&$]$&$"% Z 1,132,546 Z 1,132,546 1,079,308
3&0"'&'1($*#1V&$]$&$"% > 3,063,899 Z 3,063,899 2,735,331
G]"%&,"&% ? 46,803 Z 46,803 72,569
3&0"'$*VQ," @ 5,629 Z 5,629 667
!/72563./08 5,638,800 67,748 5,706,548 BO9Z;O;??
#Q183967<=8/3Y
!1$%$#^+(%.
HQL+&1'2$VQ," 9A 739,646 Z 739,646 Z<;O?<>
C+('1$%$#&'1($*# 99 2,060,170 Z 2,060,170 9O?>BO;?Z
/01'$&1-L"1V&$]$&$"% "M 3,157,009 111,471 3,268,480 ;O@=BO=A;
!/7258Q183967<=8 5,956,825 111,471 6,068,296 BO=B<OB;B
@87,8Q183967<=8>[63./08:8K/=8387
,5/LL8L>[;263L/363M8L70837L (318,025) (43,723) (361,748) Y;@9O;<>[
4"&YLQ%%"%[c#1$%<E$]"%&,"*&% "$ - Z - :
@87,8Q183967<=8>[63./08:8K/=872Q276/3 - - Y;@9O;<>[
-
51b1&$Q* Z - :
-
@87,8Q183967<=8>[63./082K78=72Q276/3 (318,025)
(43,723) (361,748) Y;@9O;<>[
5'1%^"'%-"&U""^+*(% MM (2,000) 2,000 Z :
@870/M8083763K<39L (320,025) (41,723) (361,748) Y;@9O;<>[
"8./3.656276/3/KK<39LY
5Q&1L^+*(%-'Q+#0&^Q'U1'( 5,016,310 155,468 5,171,778 BO=Z<OA9B
4"&,Q]","&$^+*(% (320,025) (41,723) (361,748) Y;@9O;<>[
!/725K<39L.2==689K/=P2=9 4,696,285 113,745 4,810,030 BO9>9O>>?

81#")<?%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

Z!

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

/3473IGED56E)75D56F645),-)CG4D4/GDI)D/5GHG5G67)YG4/3!83!D5G4N)G4/3F6))*+)6j864EG5K!6% D//3K45[)Y/345G4K6E[%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

567% /Q%QL$(1&"(% 7&1&","&% <B% C$1V$1L% DV&$]$&$"%% A@74% U$&0% &0"% '"a+$'","&%% ^Q'% 1% $VQ,"% 1(% "bX"($&+'"% 1VVQ+&)+("')&0")/Q,X1$"%)DV&);AAZ)1()$VL+("%)1LL)#1$%)1()LQ%%"%)'"VQ#$%"()$)&0")2"1'_%

DLL)$VQ,")1()"bX"($&+'")("'$]")^'Q,)VQ&$+$#)1V&$]$&$"%_%

81#")<@%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

!6NG756!6E)*K/^XJT%!"#!"$!#%

/3473IGED56E)MDID4/6)7J665%

)3$)%$,-$.)#/&$0102!

H;:< M!M&
@/78 X k
B6Q892LL87L
G&1#$-L"1%%"&% "b 4,106 :
51*#$-L"1%%"&% "$ 2,675,685 ;OZ9=O<?Z
2,679,791 ;OZ9=O<?Z
*<==8372LL87L
7&QVW% "' 141,701 999O<@B
E"-&Q'% M! 393,588 <;=O;AB
/1%01&-1W1($01( 1,896,564 ;O=A?OB=Z
/'"($&Q'%.1,Q+&%^1LL$#(+"U$&0$Q"2"1' M" (301,614) Y;?ZO>B=[
@87.<==8372LL87L 2,130,239 ;OBB>O<@;
!/7252LL87L58LL.<==837562:656768L 4,810,030 BO9>9O>>?
!/7253872LL87L 4,810,030 BO9>9O>>?
*N2=674K<39L
!"%&'$V&"(^+*(% MM 113,745 9BBO=Z?
K'"%&'$V&"(^+(%
E"%$#1&"(^+(% MM 2,675,685 ;OZ9=O<?Z
N""'1L^+(% MM 2,020,600 ;O=A9O@;=
K'"%&'$V&"(^+(% MM 4,696,285 BOA9ZO<9A
!/725K<39L 4,810,030 BO9>9O>>?

81#")=A%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&' (%'&)*$ "#+'"

,-'./01234'5606789':4';<2=23788>

!6NG756!6E)*K/^XJT%!"#!"$!#

/3473IGED56E)MDID4/6)7J665)Y/345G4K6E[

)3$)%$,-$.)#/&$0102

567 53849774%1VWQUL"(#")&0"$')'"%XQ%$-$L$&$"%)^Q')VQ,XL2$#)U$&0)&0")'"a+$'","&%)Q^)&0")DV&)U$&0)'"%X"V&)&Q)1VVQ+&$# '"VQ'(%)1()X'"X1'1&$Q)Q^)^$1V$1L)%&1&","*&%_

50")^$1V$1L)%&1&","&%)U"'")1XX'Q]"()1()1+&0Q'$%"()^Q')$%%+")-2)&0" 53849774%1()%$#"()Q*)&0"$')-"01L^)-2.

D='*'\5433

E1&". 06/10/2026

50")Q&"%)Q)X1#"% ==)&Q)>9)^Q',)X1'&)Q^)&0"%")^$1V$1L)%&1&","*&%_

81#")=9

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

!6NG756!6E)*K/^XJT%!"#!"$!#%

.,/0)*1)MDID4/6)7J665%

)3$)%$,-$.)#/&$0102!

H;:< M!M&
@/78 X k
B6Q892LL87L
G&1#$-L"1%%"&%
51*#$-L"1%%"&%
"b
"$
4,106
2,675,685
;OZ9=O<?Z
:
;OZ>@O>@9 ;OZ9=O<?Z
*<==8372LL87L
7&QVW% "' 141,701 999O<@B
E"-&Q'% M! 572,424 =<Z
/1%01&-1W1($01( 1,683,767 ;O;=@OA9A
/'"($&Q'%.1,Q+&%^1LL$#(+"U$&0$Q"2"1' M" (753,840) Y>;;O??Z[
@87.<==8372LL87L 1,644,052 ;OA>9O;AB
!/7252LL87L58LL.<==837562:656768L 4,323,843 =OZ?BOB@9
!/7253872LL87L 4,323,843 =OZ?BOB@9
*N2=674K<39L
!"%&'$V&"(^+*(% MM 113,745 9BBO=Z?
K'"%&'$V&"(^+(%
E"%$#1&"(^+(% MM 2,675,685 ;OZ9=O<?Z
N""'1L^+(% MM 1,534,413 9O@9BO><>
K'"%&'$V&"(^+(% 4,210,098 =OB<AO9;<
!/725K<39L 4,323,843 =OZ?BOB@9

81#")=;%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&' (%'&)*$ "#+'"

,-'./01234'5606789':4';<2=23788>

.,/0)*1 MDID4/6)7J665)Y/345G4K6E[

)3$)%$,-$.)#/&$0102

50")/Q,X12)01%)&1W")1(]1&1#")Q^)&0")"b",X&$Q)1LLQU"()+("')%"V&$Q)=A?)Q^)&0")/Q,X1$"%)DV&);AAZ)1()01%)Q& X'"%"&"()$&%)QU)%&1&","&)Q^)^$1V$1L)1V&$]$&$"%)$)&0"%")^$1V$1L)%&1&","&%)50" /Q,X12`%)"&),Q]","&)$)^+*(% ^Q')&0")2"1')U1%)Y£><@O@9=[ Y;A;B.)Y£;?AO?BA[[

567 53849774%1VWQUL"(#")&0"$')'"%XQ%$-$L$&$"%)^Q')VQ,XL2$#)U$&0)&0")'"a+$'","&%)Q^)&0")DV&)U$&0)'"%X"V&)&Q)1VVQ+&$# '"VQ'(%)1()X'"X1'1&$Q)Q^)^$1V$1L)%&1&","*&%_

50")^$1V$1L)%&1&","&%)U"'")1XX'Q]"()1()1+&0Q'$%"()^Q')$%%+")-2)&0" 53849774%1()%$#"()Q*)&0"$')-"01L^)-2.

D='*'\5433

E1&". 06/10/2026

50")Q&"%)Q)X1#"% ==)&Q)>9)^Q',)X1'&)Q^)&0"%")^$1V$1L)%&1&","*&%_

81#")=<

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

/3473IGED56E)75D56F645),-)/D7J)CI3R7%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

H;:< M!M&
@/78 X k
*2LNK5/PLK=/0/18=2763;2.76M6768L
4"&V1%0Y+%"($[cX'Q]$("(-2QX"'1&$#1V&$]$&$"% M& (171,813) Y;;@A[
*2LNK5/PLK=/063M8L763;2.76M6768L
E$]$("(%1($&"'"%&^'Q,$]"%&,"*&% - :
8+'V01%"Q^&1*#$-L"^$b"(1%%"&% (346,555) Y9;ZO<;9[
8'QV""(%^'Q,%1L"<B$]"%&,"&% - :
8+'V01%"Q^$&1#$-L"1%%"&% (4,106) -
8'QV""(%^'Q,($%XQ%1LQ^&1*#$-L"^$b"(1%%"&% 10,492 300
51b"%X1$( - -
Net cash used in inves"ng ac"vi"es (340,169) (126,021)
Change in cash and cash equivalents in the year (511,982) (349,811)
Cash and cash equivalents at the beginning of the year Mb 2,408,546 2,758,357
*2LN239.2LN8W<6M25837L277N8839/K7N8482= 1,896,564 2,408,546

81#")==%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=8! \838=25'63K/=0276/3!

567%VQ,X12%@4%1%VQ,X12%>@C@97?%-2%V8=3=E977R%50"%,",-"'%%Q^%&0"%VQ,X12%=37%&0"%93849774%1,"(%Q%X1#"%9_% G%&0"%7N7E9%<B%&0"%VQ,X12%-"$#%UQ+(%+XO%&0"%L$1-$L$&2%$%'"%X"V&%<B%&0"%#+1'1&""%@4%L$,$&"(%&Q%k9%X"'%C7CP73% Q^)&0")VQ,X12_%

:8! -../<3763;'1/56.68L!

"#$! 6+)')3789$8+9+&'3,377',+,%'+/*)&+&$:$,&)!

567%^$1V$1L%%&1&","&%%01]"%-""%X'"X1'"(%$%1VVQ'(1V"%U$&0%&0"%/01'$&$"%%I,J0%:-JI%"!MG%:%DVVQ+&$#% 1(% !"XQ'&$#% -2% /01'$&$"%.% 7&1&","&% <B% !"VQ,,"("(% 8'1V&$V"% 1XXL$V1-L"% &Q% V01'$&$"%% X'"X1'$#% &0"$'% 1VVQ+&%%$%1VVQ'(1V"%U$&0%&0"%C$1V$1L%!"XQ'&$#%7&1(1'(%1XXL$V1-L"%$%&0"%KL%1(%!"X+-L$V%<B%G'"L1(% :-JI%"!MG%:7BB7A9@N7%9%S1+1'2%;A9@[O%&0"%C$1V$1L%!"XQ'&$#%7&1(1'(%1XXL$V1-L"%$%&0"%KL%1(%!"X+-L$V%Q^% G'"L1()YC!7)9A;[)1()&0"%/Q,X1*$"%)DV&);AAZ_%

53779<D4%JQ%X$V"%53849%C7794%&0"%("^$$&$Q%B%1%X+-L$V%P7E7B@9%7E9@9F%+*("'%C!7%"!MR%)44794%1*(%@=P@>@9@74%=37% $$&$1LL2%'"VQ#$%"(%1&%0$%&Q'$V1L%VQ%&%Q'%&'1%1V&$Q%]1L+"%8E>744%<9673;@47%%&1&"(%$%&0"%'"L"]1&%1VVQ+&$#% XQL$V2_%

567% VQ%QL$(1&"(% %&1&","&% 94% <B% &0"% %+-%$($1'2% 1'"% VQ%QL$(1&"()Q)1)L$")-2)L$")-1%$%_%

567%/Q,X12%01%%&1W"%1(]1&1#"%<B%&0"%"b",X&$Q%1LLQU"(%+("'%%"V&$Q%(!#%<B%&0"%/Q,X1$"%%DV&%M!!b% 1()01%)Q&)X'"%"&"()$&%)QU%%&1&","&)Q^)^$1V$1L)1V&$]$&$"%)$)&0"%"%^$1V$1L)%&1&","&%_%

567% ^$1V$1L% %&1&","&%% 1'"% X'"X1'"(% Q% &0"% #Q$#% VQV"'% P=4@4% +("'% &0"% 0$%&Q'$V1L% VQ%&% VQ]"&$QO% ,Q($^$"()&Q)$VL+(")V"'&1$)$&",%)1&)^1$')]1L+"_)50")^$1V$1L)%&1&","&%)1'")X'"%"&"()$)%&"'L$#)U0$V0)$%)&0"% ^+V&$Q1L)V+''"V2)Q^)&0")V01'$&2)1()'Q+("()&Q)&0")*"1'"%&)k9_%

50")%$#$^$V1&)1VVQ+&$#)XQL$V$"%)1XXL$"()$)&0")X'"X1'1&$Q)Q^)&0"%")^$1V$1L)%&1&","&%)1'")%"&)Q+&)-"LQU_% 50"%")XQL$V$"%)01]")-"")VQ%$%&"&L2)1XXL$"()&Q)1LL)2"1'%)X'"%"&"()+L"%%)Q&0"'U$%")%&1&"(_%

"#"! ;3',<*%3,%$9,!

50")5'+%&""%)01]")VQ%$("'"()&0")$,X1V&)Q^)&0")V+''"&)"VQQ,$V)%$&+1&$QO)%+V0)1%)0$#0)$^L1&$Q)1()VQ%&)Q^% L$]$#)$V'"1%"%_)50"2)01]")X'"X1'"()^Q'"V1%&%)Q^)$VQ,")1()"bX"($&+'"O)1()V1%0)^LQU)^Q')&0")X"'$Q()+X)&Q% \"%/=3A6%M!Mb%=E?%7E4837%96=9%96747%=37%8D?=97?%F%P=4@4%B3%37N@7;2%=4%;7>%=4%=>><;@EV%B<3% %&'"%%:&"%&$#)($^^"'$#)^$1V$1L)V$'V+,%&1V"%)Q]"')&01&)X"'$Q(_%

567% &'+%&""%% 1'"% VQ^$("&% &01&% 96747% B<37A=494%46<;% &0"'"% 1'"%%+^^$V$"&%37473N74%1(%V1%0%&Q%-"%1-L"%&Q% VQ&$+"% ^Q'% &0"% B<37477=P>7% ^+&+'"% 50"2% ;@>>% VQ&$+"% &Q% ,Q$&Q'% &0"% $,X1V&% Q% $VQ,"% 1(% &1W"% 1XX'QX'$1&")1V&$Q)1%)"V"%%1'2%

567% &'+%&""%% &0"'"^Q'"% VQ&$+"% &Q% 1(QX&% &0"% #Q$#% VQV"'% P=4@4% <B% X'"X1'1&$Q% ^Q'% 96747% ^$1V$1L% %&1&","*&%_%

81#")=B%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

:8! -../<3763;'1/56.68L',./3763<89>!

"#%! =,%3:$!

DLL%$VQ,"%@4%'"VQ#$%"(%QV"%&0"%#'Q+X%01%%"&$&L","&%&Q%&0"%$VQ,"O%$&%@4%X'Q-1-L"%96=9%967%@EA<C7%;@>>%P7% '"V"$]"()1()&0")1,Q+&)Q^)$VQ,")'"V"$]1-L")V1)-"),"1%+'"()'"L$1-L2_%

567%'"VQ#$&$Q%<B%$VQ,"%B37V=A@74%@4%("X"("&%Q%"%&1-L$%0$#%"&$&L","&O%&0"%X'Q-1-$L$&2%<B%'"V"$X&% 1()&0")1-$L$&2)&Q)"%&$,1&")U$&0)%+^^$V$"&)1VV+'1V2)&0")1,Q+&)'"V"$]1-L")6]$("V")Q^)"&$&L","&)&Q)1)L"#1V2% 7@494% U0"*% &0"% V01'$&1-L"% VQ,X1*2% 01%% %+^^$V$"*&% 7N@?7EA7% &01&% 1% #$^&% 01%% -""*% >7B9% &Q% &0",% Y&0'Q+#0% W*QUL"(#"%<B%&0"%7@497EA7%<B%1%]1L$(%;@>>%1(%&0"%("1&0%<B%&0"%-""^1V&Q'[%1(%&0"%"b"V+&Q'%@4%4=9@4B@7?%&01&% &0"%X'QX"'&2%$%a+"%&$Q%;@>>%Q&%-"%37W8@37?%9%4=9@4BF%A=@C4%@E%967%749=97%:848=>>F%V3=E9%Q^%D3<P=97GR%J7A7@D9% <B%1%L"#1V2%C849%-"%'"VQ#$%"(%U0"%$&%@4%X'Q-1-L"%&01&%$&%;@>>%-"%37A7@N7?%1(%&0"%^1$'%]1L+"%>%#""'1LL2%-"%&0"%"bX"V&"(%V1%0%1,Q+&%&Q%-"%($%&'$-+&"(%&Q%&0"%V01'$&1-L"%VQ,X12O% V1)-")'"L$1-L2),"1%+'"(%

N'1&%%1'"%$VL+("(%$%&0"%VQ%QL$(1&"(%%&1&","&%B%^$*1*V$1L%1V&$]$&$"%%Q*%1%37A7@N=P7%-1%$%_%567%-1L1V"%Q^% $VQ,"%37A7@N7?%^Q'%4D7A@B@A%X+'XQ%"%%-+&%Q&%"bX"("(%(+'$#%&0"%X"'$Q(%@4%%0QU%$%&0"%'"L"]1&%^+(%%Q% &0"%-1L1V"%46779R%R0"'"%$VQ,"%@4%37A7@N7?%$%1(]1V"%<B%"&$&L","&%<B%'"V"$X&O%@94%'"VQ#$&$Q%@4%?7B7337?% 1(% $VL+("(% $% V'"($&Q'%% =4% ("^"''"(% $VQ,"_% R0"'"% "&$&L","&% QVV+'%% -"^Q'"% $VQ,"% @4% 37A7@N7?2% &0"% $*VQ,")$%)1VV'+"(_%

[@B94% $% W$(% (Q1&"(% ^Q'% ($%&'$-+&$Q% 1'"% $VL+("(% 1&% ]1L+1&$Q% 1(% '"VQ#$%"(% =4% $VQ,"% U0"% &0"2% 1'"% ($%&'$-+&"()&Q)&0")X'Qe"V&%)N$^&%)(Q1&"()^Q')'"%1L")1'")$VL+("()1%)$VQ,")U0")&0"2)1'")%QL(%

R0"'"%&0"%(Q1&"(%#QQ(%@4%1%^$b"(%=44792%$&%@4%,"1%+'"(%1&%^1$'%]1L+"O%8E>744%$&%@4%$,X'1V&$V1L%&Q%C7=4837%&0$%% '"L$1-L2O%$%U0$V0%A=47%&0"%VQ%&%<B%&0"%@97C%&Q%&0"%(QQ'%%0Q+L(%-"%+%"(_%567%#1$%@4%'"VQ#$%"(%=4%$VQ,"% B3C%(Q*1&$Q*%%1*(%1%VQ''"%XQ*($*#%1,Q+*&%@4%$*VL+("(%$*%&0"%1XX'QX'$1&"%^$b"(%=4479%A=44%1(%("X'"V$1&"(% Q]"')&0")+%"^+L)"VQQ,$V)L$^")$)1VVQ'(1V")U$&0)&0"%V01'$&1-L")VQ,X12`%)1VVQ+&$*#)XQL$V$"%_%

3%'"V"$X&O%(Q1&"(%X'Q^"%%$Q1L%473N@A74%1(%B=A@>@9@74%1'"%'"VQ#$%"(%Q%&0"%P=4@4%<B%&0"%]1L+"%<B%&0"%#$^&%&Q% &0"%V01'$&1-L"%VQ,X12%U0$V0%@4%&0"%1,Q+&%$&%UQ+L(%01]"%-""%U$LL$#%&Q%X12%&Q%Q-&1$%473N@A74%Q'%^1V$L$&$"%% <B% "a+$]1L"&% "VQQ,$V% -""^$&% Q% &0"% QX"% ,1'W"&d% 1% VQ''"%XQ($#% 1,Q+&% @4% &0"% '"VQ#$%"(% $% "bX"($&+'")$)&0")X"'$Q()Q^)'"V"$X&_%

GVQ,"%&1b%'"VQ]"'1-L"%$%'"L1&$Q%&Q%@EN749C7E9%$VQ,"%@4%'"VQ#$%"(%1&%&0"%9@C7%&0"%@EN749C7E9%$VQ,"%$%% 37A7@N=P>7R%

"#&! >?8$,-'&49$!

6bX"($&+'"%@4%'"VQ#$%"(%QV"%&0"'"%@4%1%L"#1L%Q'%VQ%&'+V&$]"%Q-L$#1&$Q%&Q%&'1%^"'%"VQQ,$V%-""^$&%&Q%1% &0$'(%X1'&2O%$&%@4%X'Q-1-L"%&01&%1%&'1%^"'%<B%"VQQ,$V%-""^$&%%;@>>%-"%'"a+$'"(%$%4799>7C7E9%1(%&0"%1,Q+&% B%&0"%Q-L$#1&$Q*%V1*%-"%,"1%+'"(%'"L$1-L2_%6b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i%)+%"_%

81#")=Z%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457% !"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

  • :8! -../<3763;'1/56.68L',./3763<89>!

"#&! >?8$,-'&49$!2%3,&',4$-5!

6bX"($&+'"%Q%'1$%$#%^+(%%$VL+("%%1LL%"bX"($&+'"%$V+''"(%-2%&0"%#'Q+X%&Q%3=@47%^+(%%^Q'%@94%V01'$&1-L"% X+'XQ%"%)1()$VL+("%)VQ%&%)Q^)1LL)^+('1$%$#)1V&$]$&$"%)"]"&%)1()Q:V01'$&1-L")&'1($*#_%

6bX"($&+'"% Q% V01'$&1-L"% 1V&$]$&$"%% @4% $V+''"(% Q% ($'"V&L2% +("'&1W$#% &0"% 1V&$]$&$"%% U0$V0% ^+'&0"'% &0"% V01'$&1-L")VQ,X12`%)Q-e"V&$]"%O)1%)U"LL)1%)12)1%%QV$1&"()%+XXQ'&)VQ%&%_%

DLL)"bX"($&+'")$%)$VL+%$]")Q^)$''"VQ]"'1-L")HD5_%

  • "#'! =,&$9$)&*9$%$'(+"/$!

G&"'"%&%Q%^+(%%0"L(%Q%("XQ%$&%@4%$VL+("(%U0"%37A7@N=P>7%1(%&0"%1,Q+&%V1%-"%,"1%+'"(%'"L$1-L2d%&0$%% @4% Q',1LL2% +XQ% Q&$^$V1&$Q% <B% &0"% $&"'"%&% X1$(% Q'% X121-L"% -2% &0"% $%&$&+&$Q% U$&0% ;6<C% &0"% ^+*(%% 1'"% ("XQ%$&"(_%

  • "#(! @+?+&'3,!

567%V01'$&1-L"%VQ,X12%$%%VQ%$("'"(%&Q%D=44%&0"%97494%479%Q+&%$*%81'1#'1X0%9%7V0"(+L"%Z%7CD9%B3<C%&1b1&$Q*%$*%'"%X"V&%<B%$*VQ,"%Q'%V1X$&1L%#1$*%% '"V"$]"()U$&0$*)V1&"#Q'$"%)VQ]"'"()-2)/01X&"')<)81'&)99)Q^)&0")/Q'XQ'1&$Q*)51b)DV&);A9A)Q')7"V&$Q*);BZ)Q^)&0"% 51b1&$Q*%<B%/01'#"1-L"%[=@E4%DV&%9@@;O%&Q%&0"%"b&"*&%&01&%%+V0%$*VQ,"%Q'%#1$*%%1'"%1XXL$"(%7A>84@N7>F%&Q% V01'$&1-L")X+'XQ%"%_%

  • "#)! @+,<'"/$7'?$-+))$&)+,--$89$%'+&'3,!

51#$-L"%^$b"(%=44794%VQ%&$#%k9OAAA%Q'%C<37%1'"%V1X$&1L$%"(%1(%'"VQ#$%"(%U0"%^+&+'"%"VQQ,$V%-""^$&%% 1'")X'Q-1-L")1()&0")VQ%&)Q')]1L+")Q^)&0")1%%"&)V1*)-"),"1%+'"()'"L$1-L2_%

51#$-L"%^$b"(%=44794%1'"%$$&$1LL2%'"VQ#$%"(%1&%VQ%&_%D^&"'%'"VQ#$&$QO%+("'%&0"%VQ%&%,Q("LO%&1#$-L"%B@`7?% =44794%1'"%,"1%+'"(%1&%VQ%&%>744%1VV+,+L1&"(%("X'"V$1&$Q%1(%12%1VV+,+L1&"(%$,X1$',"&%><4474R%DLL%VQ%&%% $V+''"(% &Q% -'$#% 1% &1#$-L"% ^$b"(% =4479% $&Q% @94% $&"("(% UQ'W$#% VQ($&$Q% %0Q+L(% -"% $VL+("(% $% &0"% ,"1%+'","*&)<B)VQ%&_%

E"X'"V$1&$Q%$%%V01'#"(%4<%=4%&Q%1LLQV1&"%&0"%VQ%&%744%&0"$'%'"%$(+1L%]1L+"%)L$]"%O)+%$#)&0")%&'1$#0&:L$*"),"&0Q(_%

E"X'"V$1&$Q)$%)X'Q]$("()Q)&0")^QLLQU$*#)-1%"%.%

C'""0QL()X'QX"'&2% :% ;g)%&'1$#0&)L$"% FQ&Q')]"0$VL"%% :% ;Bg)%&'1$#0&)L$"% C$b&+'"%)1()^$&&$#%% :% ;Bg)%&'1$#0&)L$"% 3^^$V")"a+$X,"&% :% ;Bg)%&'1$#0&)L$*"%

D%%"&%)+("')VQ%&'+V&$Q)1'")Q&)("X'"V$1&"()1%)&0"2)1'")Q&)2"&)QX"'1&$Q1L)U$&0$)&0")-+%$"%%_%

81#")=>%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

:8! -../<3763;'1/56.68L',./3763<89>!

"#*! =,($)&:$,&)!

C$b"()1%%"&)$]"%&,"&%)1'")1)^Q',)Q^)^$1V$1L)$%&'+,"&)1()1'")$$&$1LL2)'"VQ#$%"()1&)&0"$')&'1%1V&$Q)VQ%&% 1(%%+-%"a+"&L2%,"1%+'"(%1&%^1$'%]1L+"%1&%&0"%-1L1V"%46779%(1&"O%8E>744%&0"%]1L+"%V1Q&%-"%C7=4837?% '"L$1-L2%$%U0$V0%A=47%$&%@4%,"1%+'"(%1&)VQ%&)L"%%)$,X1$',"&)G]"%&,"&)#1$%)1()LQ%%"%O)U0"&0"')'"1L$%"()Q'% +'"1L$%"(O%1'"%VQ,-$"(%1(%X'"%"&"(%=4%lN1$%cYIQ%%"%[%Q%$]"%&,"&%i%$%&0"%VQ%QL$(1&"(%%&1&","&%Q^% ^$1*V$1L)1V&$]$&$"%%

G]"%&,"&%)$)%+-%$($1'$"%)1'")]1L+"()1&)VQ%&)L"%%)X'Q]$%$Q)^Q')$,X1$',"*&_%

"#+! A&3%B)!

7&QVW%%1'"%]1L+"(%1&%&0"%><;73%<;]C<N@EV% %&QVW%% .<49% $VL+("%% 1LL% ($'"V&% A<494% 1(% 1% 1XX'QX'$1&"% X'QXQ'&$Q% <B% ^$b"(% 1*(% ]1'$1-L"% Q]"'0"1(%%

EQ1&"(% @97C4% 7% 1'"% Q&% $VL+("(% $% &0"% ^$1V$1L% %&1&","&%% +&$L% &0"2% 1'"% %QL(% =4% &0"% 5'+%&""%)VQ%$("')$&)$,X'1V&$V1L)&Q)1%%"%%)&0")1,Q+&)Q^)(Q1&"()%&QVW)0"L(O)1%)&0"'")$%)Q)%2%&",)$)XL1V")&Q% '"VQ'(% 96747% @97C4% Q'% ]1L+"% &0",% +&$L% &0"2% 1'"% %QL(% 567% ]1L+"% <B% 96747% #QQ(%% &Q% &0"% V01'$&2% @4% $%&"1(% '"VQ#$%"()U0")&0"2)1'")%QL()$)&0")%0QX%%

C!#$,! D$"&39)!

5'1("% 1(% Q&0"'% ("-&Q'%% 1'"% '"VQ#$%"(% 1&% &0"% 4799>7C7E9% 1,Q+&% 1^&"'% 12% &'1("% ($%VQ+&% <BB737?R% 8'"X12,"&%)1'")]1L+"()1&)&0")1,Q+&)X'"X1$()"&)Q^)12)&'1(")($%VQ+&%)(+"_%

C!#$$! E+)F+&"+,B+,-',*F+,-!

/1%0%1&%-1W%1(%$%01(%$VL+("%%V1%0%1(%%0Q'&:&"',%0$#0L2%L$a+$(%@EN749C7E94%U$&0%1%%0Q'&%,1&+'$&2%Q^% &0'""),Q&0%)Q')L"%%)^'Q,)&0")(1&")Q^)1Va+$%$&$Q)Q')QX"$#)Q^)&0")("XQ%$&)Q')%$,$L1')1VVQ+*&_%

C!#$"! G'+"'/'&'$)+,-893(')'3,)!

I$1-$L$&$"%%1'"%'"VQ#$%"(%U0"%&0"'"%@4%=E%

@V=9@<E%=9%967%-1L1V")%0""&%(1&"%1%%1%'"%+L&%Q^%1%X1%&%"]"&O%@9%@4% X'Q-1-L")&01&)1)&'1%^"')Q^)"VQQ,$V)-""^$&)U$LL)-")'"a+$'"()$)%"&&L","&O)1()&0")1,Q+&)Q^)&0")%"&&L","&% V1*)-")"%&$,1&"()'"L$1-L2_%

I$1-$L$&$"%%1'"%'"VQ#$%"(%1&%&0"%1,Q+&%&01&%&0"%#'Q+X%1&$V$X1&"%%@9%U$LL%X12%9<)4799>7%&0"%("-&%Q'%&0"%1,Q+&% $&)01%)'"V"$]"()1%)1(]1V"()X12,"&%)^Q')&0")#QQ(%)Q')%"']$V"%)$&),+%&)X'Q]$("_%

8'Q]$%$Q%%1'"%,"1%+'"(%1&%&0"%-"%&%749@C=97%7%&0"%Q-L$#1&$Q%R0"'"%&0"% 7BB7A9%<B%&0"%9@C7%]1L+"%<B%,Q"2%@4%,1&"'$1LO%&0"%X'Q]$%$Q%@4%-1%"(%Q%&0"%X'"%"&%]1L+"%7A94%&0"%3@4U4%4D7A@B@A%&Q%&0"%L$1-$L$&2%567%+U$($#%<B%&0"% ($%VQ+&)$%)'"VQ#$%"()$)&0"%VQ%QL$(1&"()%&1&","&)Q^)^$1V$1L)1V&$]$&$"%)1%)1)^$1V")VQ%&_%

81#")=?%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

  • :8! -../<3763;'1/56.68L',./3763<89>!

"#$%! .',+,%'+/*',)&94:$,&)!

567%#'Q+X%QL2%01%%^$1V$1L%1%%"&%%1(%^$1V$1L%>@=P@>@9@74%Q^%1%W$()&01&%a+1L$^2%1%%-1%$V%^$1V$1L%$%&'+,"&%_% ^=4@A%^$1V$1L%$%&'+,"&%%1'"%$$&$1LL2%'"VQ#$%"(%1&%&'1%1V&$Q%]1L+"%1(%%+-%"a+"&L2%,"1%+'"(%1&%&0"$'% 4799>7C7E9%]1L+"%U$&0%&0"%"bV"X&$Q%<B%-1W%LQ1%%U0$V0%1'"%%+-%"a+"&L2%,"1%+'"(%1&%1,Q'&$%"(%VQ%&%+%$#% &0")"^^"V&$]")$*&"'"%&),"&0Q(_%

C!#$&! !8$9+&',<*/$+)$)!

!"&1L%%X1$(%+("'% QX"'1&$#%>7=474%1'"%V01'#"(%&Q%&0"%VQ%QL$(1&"(% %&1&","&%<B%^$1V$1L%1V&$]$&$"%%Q%1% %&'1$#0&:L$*")-1%$%)Q]"')&0")L"1%")&"',_%

C!#$'! H$,)'3,)!

567%V01'$&1-L"%VQ,X12%VQ&'$-+&"%%&Q%$($]$(+1L%`%("^$"(%VQ&'$-+&$Q%X"%$Q%4A67C74R%/Q&'$-+&$Q%%1'"% V01'#"()&Q)&0")73CD)$*)&0")2"1')&0"2)1'")X121-L"_%

C!#$(! .4,-*+%%34,&',<!

N""'1L% ^+(%% 1'"% +'"%&'$V&"(% ^+(%% U0$V0% 1'"% 1]1$L1-L"% ^Q'% 847% 1&% &0"% ($%V'"&$Q% <B% &0"% 53849774% $% ^+'&0"'1V")Q^)&0")#""'1L)Q-e"V&$]"%)Q^)&0"%N'Q+X%1()U0$V0)01]")Q&)-"")("%$#1&"()^Q')Q&0"')X+'XQ%"%_%

E"%$#1&"(% ^+(%% A<CD3@47% +'"%&'$V&"(% ^+(%% &01&% 01]"% -""% 479% 1%$("% -2% &0"% 53849774% B<3% X1'&$V+L1'% X+'XQ%"%_)50")1$,)1()+%")Q^)"1V0)("%$#1&"()^+()$%)%"&)Q+&)$)&0")Q&"%)&Q)&0"%^$1V$1L)%&1&","*&%_%

!"%&'$V&"(%^+(%%1'"%^+(%%U0$V0%1'"%&Q%-"%+%"(%$)1VVQ'(1V")U$&0)%X"V$^$V)'"%&'$V&$Q%)$,XQ%"()-2)(QQ'%)Q'% U0$V0%01]"%-""%'1$%"(%-2%&0"%N'Q+X%B<3%X1'&$V+L1'%X+'XQ%"%_%567%A<494%<B%'1$%$#%1(%1(,$$%&"'$#%48A6% ^+(%%1'"%V01'#"(%1#1$%&%&0"%4D7A@B@A%^+(%567%1$,%1(%847%<B%"1V0%'"%&'$V&"(%^+(%@4%479%<89%@E%967%E<974%9<% &0")^$1V$1L)%&1&","*&%%

G]"%&,"&)$VQ,"O)#1$%)1()LQ%%"%)1'")1LLQV1&"()&Q)&0")1XX'QX'$1&")^+(_%

"#$)! >:8/3I$$*"$,$7'&)!

R0"%7CD><F774%01]"%'"("'"(%473N@A7%&Q%&0"%V01'$&1-L"%VQ,X12O%%0Q'&:&"',%",XLQ2""%-""^$&%%&Q%U0$V0% &0"%7CD><F774%1'"%"&$&L"(%1'"%'"VQ#$%"(%1&%&0"%+($%VQ+&"(%1,Q+&%"bX"V&"(%&Q%-"%X1$(%$%"bV01*#"%^Q'% &01&)%"']$V"_%

"#$! J<$,%I+99+,<$:$,&)!

567%V01'$&2%1V&%%=4%1%1#"&%$%($%&'$-+&$#%^+(%%$%'"L1&$Q%&Q%&0"%XE?%,B%Z@B7%5QQLW$&%8'Qe"V&_%812,"&%%1'"% 37A7@N7?% B3<C% 4J7% 4Q&&$#01,% \% 4Q&&$#01,%0$'"% Y.^% 1(% E"'-2%0$'"% /Q,,+$&2% J"1L&0% I73N@A74R% 7+-%"a+"&)($%&'$-+&$Q%)1'"),1(")&Q)Q&0"')4J7)G/M%_%

50")^+(%)1'")"bVL+("()^'Q,)&0")%&1&","&)Q^)^$1V$1L)1V&$]$&$"%)1%)&0")V01'$&2)(Q"%)Q&)01]")VQ&'QL)Q]"')&0"% V01'$&1-L")1XXL$V1&$Q)Q^)^+(%)50")^+(%)'"V"$]"()1()X1$(O)1()12)-1L1V"%)0"L()1'")($%VLQ%"()$)*Q&");?%

81#")=@%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

  • %#! *=676.25'2../<3763;'8L760278L'239'2=82L'/K'T<9;0837!

6%&$,1&"%% 1(% e+(#,"&%% 1'"% VQ&$+1LL2% "]1L+1&"(% 1(% 1'"% -1%"(% Q% 0$%&Q'$V1L% "bX"'$"V"% 1(% Q&0"'% ^1V&Q'%O% $VL+($#)"bX"V&1&$Q%)Q^)^+&+'")"]"&%)&01&)1'")-"L$"]"()&Q)-")'"1%Q1-L")+("')&0")V$'V+,%&1*V"%_%

/'$&$V1L)1VVQ+&$#)"%&$,1&"%)1()1%%+,X&$Q%.%

567% #'Q+X% C=U74% 749@C=974% 1(% 1%%+,X&$Q%% VQV"'$#% &0"% ^+&+'"_% 567% '"%+L&$#% 1VVQ+&$#% 749@C=974% 1(% 1%%+,X&$Q%%U$LLO%-2%("^$$&$QO%47>?<C%"a+1L%&0"%'"L1&"(%1V&+1L%'"%+L&%%56737%1'"%Q%749@C=974%1(%1%%+,X&$Q%% &01&)01]")1)%$#$^$V1&)'$%W)Q^)V1+%$#)1),1&"'$1L)1(e+%&,"&)&Q)&0")V1''2$#)1,Q+&%)Q^)1%%"&%)1()L$1-$L$&$"%)U$&0$% &0")"b&)^$1V$1L)2"1')50")V01'$&2)01%)]1L+"()&0")1(($&$Q)Q^)&0")71XL$#%)-+$L($#)1()^$b&+'"%)1()^$&&$#%)0"L() U$&0$)&0")-+$L($#O)+%$#)1)-"%&)"%&$,1&")e+(#","&)50")-+$L($#)01%)-"")-1%"()Q)&0")]1L+1&$Q)X'Q]$("()-2)1) "b&"'1L)]1L+1&$Q)"&$&2)1()&0")$&"'1L)^$b&+'"%)-1%"()Q)"bX"V&"(),1'W"&)]1L+")Q^)&0")1%%"&%

  • 8! )3./08'K=/0'9/3276/3L'239'58;2.68L!

+3=8L7=6.789 "8L7=6.789 !/725 5Q&1L
K<39L K<39L K<39L ^+*(%
:;:< :;:< :;:< M!M&
X X X k
D3,+&'3,)
EQ1&$Q%1(%XQ%Q'%0$X 721,214 2,761 723,975 Z==O@B?
N$^&1$( 9<>O@=9 : 137,941 >;O>?@
GVQ,"^'Q,V01'$&1-L"&'+%&%YQ&"B[ 42,800 ==O@?? 87,788 9<@O???
GVQ,"^'Q,Q&0"'VL+-%1(Q'#1$%1&$Q% 6,600 : 6,600 9A
71XL$#%M+$L($# - : - :
;9+,&)
MM//0$L('"$4""( : - - =>O=>B
4J7/01'$&2^+(
I"#1V$"%1
(-"a+"%&%
:
410,693
-
-
-
410,693
BAA
;<?O>@<
S+L"%50Q'*" - - - 9AAOAAA
KJEM6(+V1&$Q* - 19,999 19,999 <AOAAA
6(+V1&$QC+( 70,675 - 70,675 :
1,389,923 67,748 1,457,671 9O;>=O=9<
5Q&1L;A;B 1,069,866 204,547 1,274,413

81#")BA%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

  • ?8! *N2=672:58'7=<L7L!
*N2=672:587=<L7L
+3=8L7=6.789 "8L7=6.789 !/725 !/725
B<39L K<39L K<39L K<39L
HIHJ :;:< :;:< :;:?
XX X X
DL-"'&J+*&5'+%&
D'(U$VW5'+%&
15,000
200
25,000
-
-
-
40,000
200
/"V$L!Q%"CQ+(1&$Q* 500 - 500 500
/0$L('"$4""( - - - -
/+,"'L1*(5'+%& 375 - 375 375
G*%&$&+&"Q^3+'I1(2Q^F"'V2 1,000 - 1,000 1,000
50"J+(%Q*/01'$&1-L"5'+%& - - - -
50"F1'2!Q-"'&%Q*5'+%& 2,000 - 2,000 -
50"7$'SQ061%&UQQ(CQ+(1&$Q* 2,000 - 2,000 2,000
50Q,1%S50Q'*"F",Q'$1L5'+%& 7,000 - 7,000 -
50"3''F1V$&Q%0CQ+(1&$Q* - - - -
S1,"%R$%"/01'$&1-L"5'+%& 350 - 350 -
J$%VQbCQ+(1&$QKT - - - 7,000
701'"N$^&O50"3''F1VW$&Q%0CQ+(1&$Q* 5,000 - 5,000 -
50"D(1,M"''2CQ+(1&$Q - 3,000 3,000 -
50"E+W"Q^E"]Q*%0$'"/01'$&1-L"5'+%& - 5,000 5,000 -
50"JQ%X$&1L71&+'(12C+*(/01'$&1-L"5'+%& - 2,000 2,000 -
50"S"$1CQ+(1&$Q* 1,200 - 1,200 -
50"71UL"2/01'$&$"% - - - 750
50"FQ'#1YN""'1L[/01'$&1-L"5'+%& 75 - 75 -
R$("'/Q,,+$&2CQ+(1&$QcR$("'8L1 100 - 100 -
M"*"^1V&5'+%& - - - 250
/1'(C1V&Q'2CQ+(1&$Q - - - 5,000
6&"'X'$%"FQ-$L$&2CQ+(1&$Q* 2,500 - 2,500 2,500
6'"U1%0MQ'Q+#0CQ+(1&$Q - - - 1,500
FQ''$%Q%CQ+(1&$Q* - 9,988 9,988 178
81]"'%/01'$&1-L"CQ+(1&$Q - - - 1,080
8Q%&VQ("/Q,,+*$&25'+%& - - - 100,000
50"M1''1&&E"]"LQX,"&%8I//01'$&1-L"CQ+(1&$Q* - - - 1,500
50"/L1'W"/01'$&1-L"7"&&L","*& - - - 6,000
50"F1'28Q&&"'/Q]"&JQ%X$&1L5'+%& 5,500 - 5,500 3,000
50"8+((L"I1*"5'+%& - - - 5,000
5Q2Q&1FQ&Q'F1+^1V&+'$#KT/01'$&1-L"5'+%& - - - 2,255
42,800 44,988 87,788 139,888

81#")B9%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

  • <8! )3./08'K=/0'.N2=672:58'2.76M6768L!
+3=8L7=6.789 "8L7=6.789 !/725 5Q&1L
K<39L K<39L K<39L ^+*(%
:;:< :;:< :;:< M!M&
X X X k
E"'-2\E"'-2%0$'"//N 1,048,483 - 1,048,483 9OA9@OZ;>
4Q&&$#01,/Q+&25"1V0$*#//N 2,067 - 2,067 @OZA@
6(+V1&$Q* 63,836 : 63,836 <<O@@9
F"1L%1('"^'"%0,"&% 2,202 : 2,202 ;OZAB
F$%V"LL1*"Q+% 15,958 : 15,958 9Z
1,132,546 - 1,132,546 9OA>@O<A?
5Q&1L;A;B 1,079,308 - 1,079,308
)3./08K=/0/7N8=7=2963;2.76M6768L
)3./08K=/0K<39=26L63;8M837L
+3=8L7=6.789 !/725 5Q&1L
K<39L K<39L ^+*(%
:;:< :;:< M!M&
X X k
70QX%1L"% 2,097,566 2,097,566 9OZ9BO;AA
JQ%X$V"LQ&&"'2$*VQ," 966,333 966,333 9O9;AO9<9
3,063,899 3,063,899 ;O><BO<<9
5Q&1L;A;B 2,735,331 2,735,331
  • @8! )3./08'K=/0'/7N8='7=2963;'2.76M6768L!

81#")B;%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

A8! )3M8L70837'63./08!

+3=8L7=6.789 !/725 5Q&1L
K<39L K<39L ^+*(%
:;:< :;:< M!M&
X X k
M1W$&"'"%& 46,803 46,803 >;OBZ@
46,803 46,803 >;OBZ@
5Q&1L;A;B 72,569 72,569
B8 $7N8=63./08
+3=8L7=6.789 !/725 5Q&1L
K<39L K<39L ^+*(%
:;:< :;:< M!M&
X X k
C$1V$#$VQ,"
8'Q^$&Q*($%XQ%1L%
-
5,629
-
5,629
667
-
5,629 5,629 ZZ>
5Q&1L;A;B 668 ZZ?

81#")B<%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=;8! "26L63;'K<39L'Z'M/5<372=4'63./08!

+3=8L7=6.789 !/725 5Q&1L
K<39L K<39L ^+*(%
:;:< :;:< M!M&
X X k
E$'"V&VQ%&%:Q&0"' 242,794 242,794 9Z@O=@9
E$'"V&VQ%&%:%&1^^ 496,852 496,852 =Z<O<=Z
739,646 739,646 Z<;O?<>

==8! "26L63;'K<39L'Z'K<39=26L63;'7=2963;!

A6=8.7L72KK A6=8.7/7N8= !/725 5Q&1L
./L7L ./L7L K<39L ^+*(%
:;:< :;:< :;:< M!M&
X X X k
JQ%X$V"LQ&&"'2 274,698 347,352 622,050 B=>O;@=
70QX% 808,958 579,425 1,388,383 9O;?ZO>;A
/1&"'$*# : 49,737 49,737 =9O;>;
1,083,656 976,514 2,060,170 9O?>BO;?Z
5Q&1L;A;B 1,047,720 827,566 1,875,286

E$'"V&)VQ%&%):)Q&0"')1'")&0Q%")1%%QV$1&"()U$&0)X'Q]$($#)&0")1V&$]$&2O)^Q')"b1,XL"O)LQ&&"'2)X'$h"%O)%0QX)VQ%&)Q^)%1L"%O% ("X'"V$1&$Q)1()Q&0"')VQ%&%_)DLL)VQ%&%)1'")+'"%&'$V&"(_%

81#")B=%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=:8! */L7'/K'.N2=672:58'2.76M6768L!

A6=8.7L72KK A6=8.7/7N8= :,$$/0& !/725 5Q&1L
./L7L ./L7L 9/#& K<39L ^+*(%
:;:< :;:< :;:< :;:< M!M&
X X X X k
R"LL-"$*# 453,799 54,407 355,869 864,075 >Z;OB=;
M"'"1]","*&%+XXQ'& 325,422 15,478 238,713 579,613 BBBO=>;
/Q,XL","*&1'2&0"'1X2 30,701 267 21,685 52,653 BAO99A
JQ%X$V"1&0Q," 737,336 13,953 542,661 1,293,950 9O<Z;O<?Z
5'1$$# 265,457 1,868 187,193 454,518 9@?O=@=
NQ]"'1V"VQ%&%Y*Q&"9<[ 23,671 - : 23,671 9ZO<@?
1,836,386 85,973 1,346,121 3,268,480 ;O@=BO=A;
5Q&1L;A;B 1,644,999 43,887 1,256,516 2,945,402

7+XXQ'&% A<494% Q+&L$"(% -"LQU% 01]"% -""% 1LLQV1&"(% &Q% V01'$&1-L"% 1V&$]$&$"%% $% X'QXQ'&$Q% &Q% &0"% ($'"V&% VQ%&%% 1&&'$-+&"()&Q)"1V0)1V&$]$&2_%

567% '"L"]1&% X'QXQ'&$Q%% 1'"% U"LL-"$#% MbR(d% :M!M&T% ;B_@g[O% P737=N7C7E9% %+XXQ'&% "$R$d% :M!M&T% "#R'dG2% VQ,XL","&1'2)&0"'1X2)9_Zg)Y;A;B.)9_>g[O)0Q%X$V")1&)0Q,")=A_<g)Y;A;B.)=Z_?g[)1()&'1$$*#)9_@g)Y;A;B.)Z_g[_%

!"%&'$V&"(% "bX"($&+'"% &Q&1LL$#% k999O=>9):M!M&T% k@=O<=9[% @4% $VL+("(% $% &0"% &Q&1L% "bX"*($&+'"% <B% k<O;Z?O=?A) Y;A;B.)k;O@=BO=A;[_%

&<11/=7!./L7L!

:;:< M!M&
X k
D(,$$%&'1&$Q 1,288,130 9O;A>OB?A
F1'W"&$*# 57,911 =@O;;9
1,346,041 9O;BZO?A9

81#")BB%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=C8! \/M8=323.8'./L7L!

H;:< M!M&
X k
E$'"V&VQ%&%:Q&0"' 23,671 9ZO<@?
23,671 9ZO<@?

3&0"'%#Q]"'1V"% A<494%'"X'"%"&%1+($&% B7742%L"#1L%A<494%1(%0"1L&0%\%%1^"&2%1+($&%A<494R%%

=>8! @87!63./08[,8Q183967<=8>!

H;:< M!M&
X k
E"X'"V$1&$QQ^&1#$-L"^$b"(1%%"&%:QU*"(-2&0"V01'$&2 233,345 9Z@O@>>
D+($&Q'`%'",+"'1&$Q–1+($& 28,000 ;?OZAA
D,Q'&$%1&$QQ^$&1*#$-L"%Q^&U1'" 1,369 :
&72KK./L7L
\=/<1 N'Q+X */01234 /Q,X1*2
:;:< M!M& :;:< M!M&
X k X k
R1#"%1*(%1L1'$"% 3,586,448 3,350,092 3,538,643 <O<BAOA@;
7QV$1L%"V+'$&2VQ%&% 407,735 270,519 400,927 ;>AOB9@
/Q&'$-+&$Q&Q("^$"(VQ&'$-+&$QX"%$Q* 304,226 330,738 251,821 <<?
4A67C74
4,298,409 3,951,349 4,191,391 <O@B9O<=@

=?8! &72KK'./L7L!

81#")BZ%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=?8! &72KK'./L7L',./3763<89>!

50")1]"'1#")+,-"')Q^)X"'%Q%)",XLQ2"()-2)&0"%/Q,X12%(+'$#)&0"%2"1'%;=4)=4)B<>><;4T%

\=/<1 N'Q+X
:;:< M!M&
@/] 4Q_
E$'"V&V01'$&1-L" 64 $M
C+('1$%$#1*(X+-L$V$&2 64 b&
F11#","&1(1(,$$%&'1&$Q* 25 Mb
153 "b|

50")+,-"')Q^)",XLQ2""%)U0Q%")",XLQ2"")-""^$&%)Y"bVL+($#)",XLQ2"')X"%$Q*)VQ%&%[)"bV""("(%kZAOAAA);=4T%

\=/<1 N'Q+X
H;:< M!M&
@/] 4Q_
G&0"-1(kZAOAA9:k>AOAAA 1 9
G&0"-1(k>AOAA9:k?AOAAA 0 9
G&0"-1(k?AOAA9:k@AOAAA - :

The total amount of employee benefits received by key management personnel, including employer's NI and pension, is £375,774 (2025: £418,375). The Trust considers its key management personnel to comprise the Chief Execu"ve Officer, Director of Clinical Services, Company Secretary, Head of Finance and Director of Income Genera"on and Marke"ng,.

No Trustees were paid any remunera"on during the year. No Trustees were reimbursed travel expenses during the year for their par"cipa"on in volunteering in line with the charitable company's expense policy.

Treetops Hospice Trust makes payments on behalf of employees into individuals' defined contribu"ons pension schemes. The assets of these schemes are held separately from those of the charity in independently administered funds. The pension cost charge in the Statement of Financial Activities represents contribu"ons payable by the charity to the funds and amounts to £304,226 (2025: £330,738). At the year end, contribu"ons of £25,999 (2025: £27,706) were outstanding_%

81#")B>%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=<8 )3723;6:582LL87 !/725 !/725
:;:< :;:?
X X
E3)&39(+/4+&'3,
D&9DX'$L;A;B - :
D(($&$Q*% BO=>B :
D&<9F1'V0;A;Z
5,475 -
J:39&')+&'3,
: -
D&9DX'$L;A;B
/01'#"^Q'&0"2"1' 1,369 D
D&<9F1'V0;A;Z
1,369 -
4"&MQQWH1L+" 4,106 ]

81#")B?%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=@8! !23;6:58'K6Q89'2LL87L'!

\=/<1!239!*/01234!

B=88N/59 -LL87L<398= D/7/= B6Q7<=8L239 $KK6.8 !/725
1=/18=74 ./3L7=<.76/3 E0F3GH04 K67763;L 8W<610837 X
X X X X X
E3)&39(+/4+&'3,
D&9DX'$L;A;B CI;A>ICA? =CBI@;; ===ICC; BC@IBA; =C:I;A< >I>;?I>A=
D(($&$Q*% FFOJII Z :CI><: :@@I<<A GGO`Ha C><I???
E$%XQ%1L% Z ,GF^O_II> 9C>I@?C6 9:C:IBA@6 ,bIObI^> 9>>@IA>B6
D&<9F1'V0;A;Z CI==@IBA? D =;;I;CB BA:I<<= =;CI?;: bOFIbOG`_
D$89$%'+&'3,
D&9DX'$L;A;B AC:I:@A Z ?=I@A; @BCI;A< ==CIB?= =I@B=I;B?
/01'#"^Q'&0"2"1' <:I<?? Z HJOaFG =:?I><; =AI<BB :CCIC>?
3*($%XQ%1L% Z Z 9:BIAB:6 ,HFHO^`J> ,bIObI^> 9C;CI:A@6
G,X1$',"*&'"]"'%1L ,^HOJaG> D Z Z Z 9B:I<?=6
D&<9F1'V0;A;Z A;:I:A: - >AI>=B <A?I?<; B:I:>= =I<:AI?;:
K$&"33B(+/4$
D&<9F1'V0;A;Z :IC=?I@;C D ?=I<:; :B@I=;= GGOHJG :I<@?I<A?
D&<9F1'V0;A;B ;O;B;O9A> 9<@O>AA B@OBBA 9==O?@= 9?O9<B ;OZ9=O<?Z

567%53849774%1'"%<B%&0"%QX$$Q%&01&%&0"%QX"%,1'W"&%]1L+"%<B%&0"%^'""0QL(%X'QX"'&2%@4%$%7`A744%<B%@94%V1''2$#% ]1L+"_)G&)$%)Q&)VQ%$("'"()X'1V&$V1L)&Q)a+1&$^2)&0$%)"bV"%%_%

81#")B@%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=@8! !23;6:58'K6Q89'2LL87L',./3763<89…>'!

50")VQ%&)Q^)&0")^'""0QL()X'QX"'&2)VQ,X'$%")Q^)&0")-+$L($#%)1()#'Q+(%)WQU*)1%)5'""&QX%)JQ%X$V")5'+%&_%

H;:< M!M&
X k
3'$#$*1LVQ%&% 246,882 ;=ZO??;
G,X'Q]","*&%&Q^'""0QL(X'QX"'&2 1,362,617 9O;@OA9
71*($1V'"X'",$%"% 167,941 9Z>O@=9
4"U-+$L(VQ%&% 765,545 >ZBOB=B
71XL$#%-+$L($# 575,000 B>BOAAA
3,117,985 <OA?=O<?B

=A8! B6Q89'2LL87'63M8L70837L!

\=/<1'!

50"'")1'")Q)^$b"()1%%"&)$]"%&,"&%)0"L()1&)#'Q+X)L"]"L)^Q')&0")2"1')"();A;Z)Q');A;B_))%

81#")ZA%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

=A8! B6Q89'2LL87'63M8L70837L',./3763<89>!

*/01234!

)3M8L70837 !/725 Total
63L<:L6962=4 :;:< 2025
X X £
E3)&39(+/4+&'3,
D&9DX'$L;A;B 11,000
11,000 11,000
D(($&$Q*% : - -
E$%XQ%1L% : - -
!"]1L+1&$Q*% : D :
D&<9F1'V0;A;Z 11,000 11,000 99OAAA
G]"%&,"&V1%0 : - -
99OAAA 11,000 99OAAA
D&<9F1'V0;A;B

50")$]"%&,"&)$)L$%&"()%"V+'$&$"%)'"X'"%"&%)1)XQ'&^QL$Q)$]"%&,"&)&01&)U1%)0"L(% -2% !1&0-Q"%% G]"%&,"&% F11#","*&% I&(_% %

81#")Z9%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

B6Q89'2LL87'63M8L70837L',./3763<89>!

%=63.6125'L<:L6962=68L!

50")^QLLQU$#%U"'")%+-%$($1'2)+("'&1W$#%%Q^)&0"%/Q,X12.%

@208L *52LL/K (/5963; )3.5<98963
LN2=8L ./3L/569276/3
5'""&QX%!"&1$LI$,$&"( 3'($*1'2 "!!d 174
5'""&QX%C+($#I$,$&"( 3'($*1'2 "!!d 174
50"^$1V$1L'"%+L&%Q^&0"%+-%$($1'$"%^Q'&0"2"1';737T
@208L )3./08 #Q183967<=8 %=/K67[,C/LL> @872LL87L[
X X K/=7N8482= ,562:656768L>
X £
5'""&QX%!"&1$LI$,$&"( Z D D 9C?I?A:6
5'""&QX%C+($#I$,$&"( IB<< 9C;<IA;;6 C@AI=<< ?C:I@<B
=B8 &7/.SL
\=/<1 N'Q+X */01234 /Q,X1*2
:;:< ;A;B :;:< M!M&
X £ X k
EQ*1&"(%&QVW =>=I@;= 111,395 =>=I@;= 999O<@B
:;8 A8:7/=L
\=/<1 N'Q+X */01234 /Q,X1*2
:;:< M!M& :;:< M!M&
X k X k
5'1("("-&Q'% 116,845 73,503 116,845 73,503
Amounts owed by group undertakings - - 186,793 153,673
Other debtors 3,629 (3,934) - (6,851)
Prepayments and accrued income 273,114 254,636 268,786 213,351
393,588 324,205 572,424 433,676

81#")Z;%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

:=8! *=8967/=LY'-0/<37L'K25563;'9<8'P67N63'/38'482=!

\=/<1 N'Q+X */01234 /Q,X1*2
:;:< M!M& :;:< M!M&
X k X k
D,Q+&%0"L(+("'1#"V21''1#","&YQ&"
;'G 41,509 =ZO@@@ 41,509 =ZO@@@
5'1("V'"($&Q'% 124,818 9;BOB?? 118,698 9A<O?A9
D,Q+&%QU"(&Q#'Q+X+("'&1W$*#% Z : 534,047 B==O==B
3&0"'&1b1&$Q1(%QV$1L%"V+'$&2 59,156 =;O;AA 59,156 =;O;AA
3&0"'V'"($&Q'% 29,907 <BOZ9; (34,534) Y=ZO>;Z[
DVV'+1L%1(("^"''"($VQ," 46,224 <ZO<BB 34,964 <;O9B>
301,614 ;?ZO>B= 753,840 >;;O?>Z

81#")Z<%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

::8 &72780837/KK<39L
&72780837/KK<39L–.<==837482=
R2523.827G !=23LK8=L \263L[ R2523.827FG
-1=65HIHa )3./08 #Q183967<=8 3,J5-K ,C/LL8L> D2=.NHIHJ
X X X X X X
L,9$)&9'%&$-
D$)'<,+&$-74,-)
C$b"(1%%"&% :I<=>ICA< JGOH^^ Z D Z :I<@?I<A?
;$,$9+/74,-)
N""'1L^+(% =IB=?I@C@ >IAB:I?C? 9?I<?;I;:?6 F_JOGJJ D =I?C>I>=C
5'""&QX%C+($# ?::I@<B IB<< 9C;<IA;;6 9C@AI=<<6 Z ?::I@<B
5'""&QX%!"&1$L 9C<I?A:6 Z D Z Z 9C<I?A:6
HObIGO^Hb aOa__OaIG 9?IB?<IA:?) 9:I;;;6 D :I;:;I<;;
@3&+/L,9$)&9'%&$-
74,-) ?I;=<IC=; aOJFOII ,aO^aJOHa>|9:I;;;6|Z|bOJ^JOHa
0$)&9'%&$-74,-)
N'Q+(%^+( =CI>C? GOH ,aOb^^> Z Z BI@<>
R"LL-"$*#/1^é F_OFJa D 9:CI=B<6 Z Z =>I=<B
R"LL-"$*#
50"'1X2 =@I;;; HOIII ,GbOJGF> HOIII Z <ICA@
41&$Q*U$("
/Q,X1%%$Q*1&"
/Q,,+*$&$"% =@IB;> aII Z Z Z =AI>;>
JQ%X$V"KTN'1*& bOHJF D Z Z Z bOHJF
/Q&",XL1&$Q
/Q+'&21'( ?IC<@ D D Z Z ?IC<@
KJEM6(+V1&$Q* GIOIII G^O^^^ ,H^O^^^> D Z Z
!Q1,$*#4+'%"
/1'C+*( bOFIb Z Z D Z >IC;>
72'$*#"E'$]"'
N'1*& Z D 9>A<6 D Z ,b`J>
/0$L('"$4""( ,J_I> D Z Z Z 9<@;6

81#")Z=%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

::8
&72780837/KK<39L,./3763<89>
::8
&72780837/KK<39L,./3763<89>
A&+&$:$,&3774,-)–%499$,&I$+9
R2523.827G !=23LK8=L \263L[ R2523.827FG
-1=65HIHa )3./08 #Q183967<=8 3,J5-K ,C/LL8L> D2=.NHIHJ
X X X X X X
S+L"%50Q'*" <>OBAA : Y<>OBAA[ : : -
/0""&01,/"*&'" @OAAA 9?O<<9 Y??[ : : 27,243
H$'&+1LR1'( : ;BOAAA : : : 25,000
=??I><A <@I<?A 9===ICA=6 :I;;; Z ==CI@>?
@3&+/3774,-) ?I=@=I@@A ?I@;?A 9<I;<AI:;<6 D D >IA=;I;C;

81#")ZB%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

TRE￿0P5 HOSPICE TRUST IA company limited by guarantee) NOTESTO THE FINANCIALSTATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 22. statement of funds Icontinuedl statement oAfvnds-Prior B*rKÈat31 inlTh Fthed assets {43W} 6W386 General funds U73S19 417.591 127&0711 L915.737 TreetOP5 Fun(h TreetOP5 Retsil 5a769 (a6￿82) 5a769 13&5821 I759.￿ 41957.741 L4L924 5A17.752 4957.741 1&35%1231 5a1￿310 U9 I9.3G61 Childrtr's Support ar#8 Natiofiwidè Con¥Jassionat• C4mrnunities 17. 17.9)a Hospice UK Gr•nt 4263 ContsM￿atl1?n Cofftard NHS Ch¥ity Fwd Roamir% Nurse Car Fund Grant Chilthw in Need Rsign Envebpe ID". ENV5981gow541WDBAE-2014-CBFE 08110r2026 11".￿￿￿1 UTC Page 66

Children i n N eed

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

81#")Z>

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

::8! &72780837!/K'K<39L',./3763<89>!

A8L6;32789'B<39L!

E"%$#1&"()^+(%)VQ,X'$%")&0")"&)-QQW)]1L+")Q^)&0")#'Q+X`%)+'"%&'$V&"()^$b"()1%%"&%_%

"8L7=6.789'B<39L!

N'Q+(%)^+():)^Q'),1$&1$$#)&0")#'Q+()%+''Q+($#)&0")JQ%X$V"_%

/0$L('"`%%P737=N7C7E9%X'Qe"V&%:%&Q%X12%4=>=3@74%<B%VQ+%"LL$#%1(%",Q&$Q1L%%+XXQ'&%49=BB%U0Q%X'Q]$("%473N@A74% &Q)-"'"1]"()V0$L('"_%

R"LL-"$#)/1^m)$%)1)^+()&Q)$%&1LL)1)%"L^)%"']$V")V1&"'$#)1'"1)U$&0$)&0")U"LL-"$#)1'"1_)%

41&$QU$("%/Q,X1%%$Q1&"%.<CC8E@9@74%8'Qe"V&%:%"%&1-L$%0"(%&Q%"#1#"%1(%7CD<;73%X"QXL"%1(%VQ,,+$&$"%% &Q% 01]"% VQ]"'%1&$Q%% 1-Q+&% ("1&0O% (2$#O% P737=N7C7E9% 1(% ><442% +L&$,1&"L2% "1-L"% X"QXL"% &Q% %01'"% &0"$'% X'"^"'"V")1*()U$%0"%)1-Q+&)&0"%"_%

5'1+,1%:%Q:&1LW$#%&0"'1X2%^Q'%V0$L('"%1(%2Q+#%X"QXL"%U0Q%01(%"bX"'$"*V"(%4<C7%&'1+,1%&0'Q+#0%&0"$'% P737=N7C7E9R%

JQ%X$V"%KL%:%567%4J76%1U1'("(%^+($#%&Q%1LLQU%&0"%0Q%X$V"%&Q%,1W"%1]1$L1-L"%-"(%V1X1V$&2%1(%VQ,,+$&2% %+XXQ'&% B3<C% DX'$L% M!M!% &Q% S+L2% M!M!% &Q%X'Q]$("%%+XXQ'&% &Q%X"QXL"%U$&0%VQ,XL"b%E77?4%$%&0"%VQ&"b&%<B%&0"% .,SY+�!"'%%$&+1)nQ%1(%&Q%X'Q]$("%-"(%V1X1V$&2%=E?%A<CC8E@9F%48DD<39%B3<C)*<N7CP73%M!M!%9<%/=3A6%M!M"%B<3% &0")%1,")X+'XQ%"_%

/Q&",XL1&$Q% /Q+'&21'(% :% &Q% X'Q]$("% 1% X"1V"^+LO% VQ&",XL1&$]"% 1'"1% %+''Q+($#% Q+'% F",Q'2% 5377% $% U0$V0% X"QXL")V1)'",",-"')LQ]"()Q"%)U0Q)01]")($"(_%

K$]"'%$&2)JQ%X$&1L)E"'-2)1()M+'&Q)#'1&)$%)&Q)VQ&'$-+&")&QU1'(%);)(12%)1)U""W)&'1$$*#)^Q')^+LL)&$,")%&1^^_)%

R"LL-"$#)50"'1X2)^+()$%)&Q)VQ]"'&)&0")QL()-1&0'QQ,)$&Q)1)&0"'1X2)%X1V"_)%

!Q1,$*# % 4+'%"% /1'% C+(% :% &Q% X+'V01%"% 1% N76@A>7% U0$V0% V1% -"% +%"(% -2% &0"% !Q1,$#% 4+'%"% &"1,% &Q% X'Q]$("% %X"V$1L$%"()Q]"'$#0&)V1'"_%

S+L"%) 50Q'") ^+() $%) 1) ;) 2"1') X'Qe"V&) &Q) ^+() ;) +'%"%) &Q) X'Q]$(") &'1$$#) 1() "(+V1&$Q) Q) 1'"1) U1%0$#) &Q) %+''Q+($#)V1'")0Q,"%_)%

/0""&01,)/"&'")$%)1)^+()&Q),Q("'$%"()1()'"X+'XQ%")&0")/0""&01,)/"&'")&Q)$VL+(")%Q+(X'QQ^$#O)X'$]1V2)1() V0$L()-"'"1]","&)&0"'1X2_)%

!=23LK8=L!

E+'$#)&0")2"1'O%1)&'1%^"')01%)-""),1("%-"&U"")#""'1L)^+(%)1()("%$#1&"()^+(%)$)'"L1&$Q)&Q)^$b"()1%%"&%_% 567%&'1%^"'%%'"X'"%"&%1%C<N7C7E9%$%4MH%Q%^$b"(%=44794R%D)&'1%^"')Q^)£;OAAA)01%)-""),1(")-"&U"")#""'1L) ^+(%) 1() R"LL$#) -"$#) 50"'1X2O) '"L1&$#) &Q) 1) ,$%VL1%%$^$V1&$Q) Q^) 1) #'1&) $) &0") X'$Q') 2"1'% D% &'1%^"'% <B% k\$b2"''% (2025: 435,432) % ;=4% 1L%Q% ,1("% -"&U""% N""'1L% C+(%% 1(% 53779<D4% C+($#% $)+'"%&'$V&"() ^+(%O)'"X'"%"&$#)&0")#$^&)1$()X12,"&),1(")^'Q,)&0")%+-%$($1'2)&Q)&0")X1'"&)$)&0")2"1'_)D)&'1%^"')Q^)£;OAAA) Y;A;B.)£$L[)&Q)'"^L"V&)1)X'$Q')2"1')'"%&'$V&"()$VQ,")^'Q,)R"LL-"$#)50"'1X2)&01&)U1%)VL1%%$^$"()1%)#""'1L)^+(%)1%) &0")5'+%&)U1%)+1U1'")&01&)&0")#'1*&)U1%)'"%&'$V&"()%

81#")Z?%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

!

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

:C8! &<002=4'/K'K<39L!

&<002=4'/K'K<39L'Z'.<==837'482=!

R2523.827G !=23LK8=L \263L[ R2523.827FG
-1=65HIHa )3./08 #Q183967<=8 3,J5-K ,C/LL8L> D2=.NHIHJ
X X X X X X
E"%$#1&"(^+(% "#$%&#'($ JGOH^^ D D Z HOJ_aOJ`a
N""'1L^+(% "#&)%#*"& 5,577,501 9?IB?<IA:?6 9:I;;;6 D HOIHIOJII
!"%&'$V&"(^+*(% %++#&$( J_OJa` 9===ICA=6 :I;;; Z GGFO_ba
?I=@=I@@A ?I@;?A 9<I;<AI:;<6 Z D >IA=;I;C;
&<002=4/KK<39LZ1=6/=482=
M1L1*V"1&
<9F1'V0
M!M&
M1L1V"1&
DX'$L;A;=
53=E4B734
$
cQ+&
N1$%c
:Z<4474G
9
G
VQ,"
6bX"*($&+'"
k k k k k k
E"%$#1&"(^+(% ;OA?<O9A< ZB;OAAA Y9=AO><<[ ZZ : ;OZB?OA=Z
N""'1L^+(% <OAZ =O?A=OAB9 YBOA9ZO@=B[ YZZ[ : ;O>B@O>AZ
!"%&'$V&"(^+*(% >>O=Z; ;OZ?9 Y<=O??A[ : : =BO;Z<
BO9@ZO?=9 BO=B?O><; YBO9@;OBB?[ : : BO=Z<OA9B
  • :>8! -3254L6L'/K'387'2LL87L':87P883'K<39L!

-3254L6L'/K'387'2LL87L':87P883'K<39L'Z'.<==837'482=!

+3=8L7=6.789 "8L7=6.789 !/725
K<39L K<39L K<39L
:;:< :;:< :;:<
X X X
G&1#$-L"1%%"&% 4,106 : ;<=>?
51*#$-L"1%%"&% 2,675,685 : @<?AB<?CB
/+''"*&1%%"&% 2,318,108 113,745 "#&'%#(+'
/'"($&Q'%(+"U$&0$Q"2"1' (301,614) : ,')%#$%&-
!"#$% 4,696,285 113,745 >IA=;I;C;

81#")Z@%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

  • :>8! -3254L6L'/K'387'2LL87L':87P883'K<39L',./3763<89>!

  • -3254L6L'/K'387'2LL87L':87P883'K<39L'Z'1=6/='482=!

K*'"%&'$V&"( J7493@A97? 5Q&1L
^+*(% ^+*(% ^+*(%
M!M( M!M( M!M(
k k k
51*#$-L"^$b"(1%%"&% 2,658,046 : ;OZB?OA=Z
C$b"(1%%"&$]"%&,"&% - : :
/+''"*&1%%"&% 3,058,473 45,263 <O9A<Z
/'"($&Q'%(+"U$&0$Q"2"1' Y;@?O>Z>[ : Y;@?O>Z>[
@3&+/ 5,417,752 45,263 BO=Z<OA9B
:?8 "8./3.656276/3/K3870/M8083763K<39L7/387.2LNK5/PK=/0/18=2763;2.76M6768L
\=/<1 N'Q+X
:;:< M!M&
X k
4"&Y"bX"($&+'"[c$VQ,"^Q'&0"2"1'Y1%X"'7&1&","&Q^C$1*V$1LDV&$]$&$"%[ (361,748) Y;@9O;<>[
J-#4)&:$,&)739M
E"X'"V$1&$Q*V01'#"% 233,345 9>AOA>>
:
G,X1$',"&'"]"'%1L
YN1$
%[cLQ%%"%Q($%XQ%1L%Q^^$b"(1%%"&%
YG
V'"1%"[c("V'"1%"$%&QVW%
YG
V'"1%"[c("V'"1%"$("-&Q'%
G
V'"1%"cY("V'"1%"[$*V'"($&Q'%
(92,651)
134,070
(30,306)
(69,383)
14,860
YY>O=B=[
Y?;O?ZB[
Y9;OA99[
K$&%+)F24)$-',5N893('-$-"I38$9+&',<+%&'('&'$) (171,813) Y;;@A[

81#")>A%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

  • :<8! -3254L6L'/K'.2LN'239'.2LN'8W<6M25837L!
\=/<1 N'Q+X
:;:< M!M&
X k
/1%0$01( 1,896,564 ;O=A?OB=Z
@3&+/%+)F+,-%+)F$O4'(+/$,&) 1,896,564 ;O=A?OB=Z
-3254L6L/K.N23;8L6338798:7
-7G-1=65 *2LN -7FGD2=.N
H;:? K5/PL :;:<
X X
X
/1%01&-1W1($01( :I>;AI?>< 9?==IBA:6 =IAB<I?<>
:I>;AI?>< 9?==IBA:6=IAB<I?<>
  • :@8! -3254L6L'/K'.N23;8L'63'387'98:7!

81#")>9%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

:A8! $18=2763;'582L8'./00670837L!

D&%<9)F1'V0);A;Z)967%N'Q+X)1(%&0"%/Q,X12%01()VQ,,$&,"&%)&Q),1W")^+&+'"),$$,+,)L"1%")X12,"&%)+("'% Q:V1V"LL1-L")QX"'1&$#)L"1%"%)1%)^QLLQU%.%

\=/<1 N'Q+X
:;:< M!M&
X k
4Q&L1&"'&01*92"1' 235,900 208,120
Later than 1 year and not later than 5 years 768,050 615,404
Later than 5 years 159,150 236,723
1,163,100 1,060,247

56737%;=4%k;AOA?@%:M!M&T%k;=O9@A[%7=47%X12,"&%%'"VQ#$%"(%=4%1%7`D7E47%$%&0"%%&1&","&%<B%^$1*V$1L% 1V&$]$&$"%_%

:B8! -;83.4'2==23;80837L!

567%V01'$&2%1V&%%1%%1%1#"&%@E)($%&'$-+&$#%63I5%X'Qe"V&%^+(%%YE)&0"%1VVQ+&$#%X"'$Q()"($#%<9%F1'V0%;A;Z%&0" V01'$&2%37A7@N7?%k=9OBA@%:M!M&T%k=ZO@@@[)1()($%-+'%"()k$L)Y;A;B.%k$L[)^'Q,)&0")^+(%D)1,Q+&%Q^%k=9OBA@ Y;A;B.)£=ZO@@@[% @4% $VL+("(% $% Q&"% M"% '"L1&"(% &Q% +($%&'$-+&"(% ^+(%% &01&% 1'"% '"X121-L"% &Q% 4J7 4Q&&$#01,% 1()4Q&&$#01,%0$'")G/M)1()E"'-2%0$'")/Q,,+$&2)J"1L&0)7"']$V"%_%

81#")>;%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC

"#$$"%&''(%'&)*$'"#+'"!

,-'./01234'5606789':4';<2=23788>!

43567)53)5J6)CG4D4/GDI)75D56F6457%

!"#$%&'$(')#$'*+'+$,-$.)#/&$0102!

C;8! "852789'12=74'7=23L2.76/3L!

E+'$#%&0"%2"1'O%""%&'+%&""%%,1("%(Q1&$Q%%&Q&1LL$#%k=?;%:M!M&T%\%&'+%&""%O%k<O=<>[%D%+,-"'%4<% (Q1&")#QQ(%)&Q)&0")'"&1$L)%0QX%%

E+'$#%&0"%2"1'%&0"%V01'$&2%37A7@N7?%$VQ,"%OB@9%:M!M&T%k9OA?BO@Z9[%B3<C%53779<D4%C+($#%I$,$&"(%567% V01'$&2%$V+''"(%7`D7E474%[%Q)-"01L^%Q^%5'""&QX%%C+($#%I$,$&"()1()k$L%Y;A;B.%k9<[)Q*)-"01L^) Q^)5'""&QX%)!"&1$L)I$,$&"(%

53779<D4%!"&1$L%I$,$&"(O%1%48P4@?@=3F%<B%967%A6=3@9F2%<;7?%1%P=>=EA7%<B%k9#b2$'(%:M!M&T%k"M&2&!#G%=9%967%F7=3%7E?2% U0$V0)$%)$VL+("()U$&0$)("-&Q'%_%

567%V01'$&2%QU"(%53779<D4%C+($#%I$,$&"(O%1%%+-%$($1'2%<B%&0"%VQ,X12O%kB<=OA=?%:M!M&T%kB;ZOZA=[%1&%&0"%2"1'% "(O%U0$V0%@4%$VL+("(%U$&0$%V+''"&%L$1-$L$&$"%_%D%#$^&%1$(%X12,"&%;=4%,1("%B3<C%53779<D4%C+($#%I$,$&"(%&Q% 5'""&QX%)JQ%X$V")5'+%&)$)&0")2"1')&Q&1LL$#)k<>?O9ZZ)Y;A;B.)k=<BO=<;[_%

^79;77E%&0"%%+-%$($1'2%VQ,X1$"%%&0"'"%;=4%1%-1L1V"%<B%k;AOZ9=%:M!M&T%k;9OA=B[%QU"(%-2%53779<D4%!"&1$L% I$,$&"()&Q)5'""&QX%)C+($#)I$,$&"(_%

C=8! */37=/5563;'12=74!

50")VQ,X12)$%)VQ&'QLL"()-2)$&%),",-"'%)4Q)$($]$(+1L),",-"')01%)Q]"'1LL)VQ&'QL%

81#")><%

RSign Envelope ID: ENV59619004-5419-DBAE-3014-CBFE 08/10/2026 11:00 AM UTC